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Ultrahigh-resolution, low-dose rescans in a region of interest following a general screening computed tomog-
raphy (CT) scan is motivated by the need to reduce invasive tissue biopsy procedures in cancer screening.
We describe a new method to meet the conﬂicting demands of ultrahigh resolution, high-speed and ultralow-
dose, and the ﬁrst proof-of-concept experiment. With improving detector resolution, the limiting factor for the
system resolution of whole-body CT scanners shifts to the penumbra of the source focal spot. The penumbra
unsharpness is minimized by inserting ﬂat-panel detector(s) that are in direct contact with the body. In the
hybrid system, the detector insert and the CT detector acquire data simultaneously, whereby the standard CT
images give the position and orientation of the detector insert(s) as needed for tomosynthesis reconstruction.
Imaging tests were performed with a compact photon-counting detector insert on resolution targets of both
high- and low-contrast as well as a mouse specimen, all inside a body phantom. Detector insert tomosynthe-
sis provided twice the resolution of the CT scanner alone at the same dose concentration. The short 2-cm
beam collimation of the tomosynthesis rescan gave an effective dose equivalent to 6% of an average CT
scan in the chest or abdomen.
INTRODUCTION
Driven by the desire to reduce invasive biopsy procedures in cancer
screening, technologies are being rapidly developed to provide
ultrahigh resolution in a limited region of interest, which allows a
detailed rescan of a suspect area revealed by a standard scan while
the patient is still in the computed tomography (CT) scanner (1-3).
The CT system resolution is inﬂuenced by the detector resolu-
tion, the size of the x-ray tube focal spot and the local dose
concentration (CTDIvol). To realize a high-resolution rescan in
standard whole-body CT scanners, protocols have been developed
to increase the CTDIvol by multiple fold in a short Z length to
provide high-resolution locally (3); further improvement comes
with the recent implementation of ultrahigh-resolution multirole
detectors in whole-body CT scanners (1) and high-resolution pho-
ton-counting detectors (2). With such detectors, the limiting factor
of resolution becomes the focal spot penumbra, namely, blurring of
the images by the ﬁnite size of the x-ray source spot. One approach
to overcome the focal spot limit is a system design that includes a
micro focus source on an inner ring inside the scanner bore. But it
has yet to be realized owing tomajor engineering changes to the CT
system.
On the other hand, because the focal spot penumbra is
proportional to the distance between the object and the image
plane, contact radiography and mammography minimize the
distance to achieve excellent resolution with relatively large
focal spots. Based on this idea, we describe an alternative
method to break the focal spot limitation in clinical whole-body
CT scanners, and the ﬁrst experimental demonstration. The
general idea is to add detector inserts inside the CT bore which
are in direct contact with the body, for example, on the patient
bed (Figure 1A). In this conﬁguration, the focal spot penumbra
on the detector insert is reduced by several fold when compared
to the existing CT detector in the rotating gantry (Figure 1B). In
operation, the detector inserts are mechanically shifted out of
view during the standard CT scan, and shifted into the bore for
the high-resolution rescan. A unique synergy of this hybrid
system is the simultaneous data acquisition by the detector
insert and the CT detector during the high-resolution rescan:
images from the CT detector show the position and orientation
of the detector insert inside the bore, which is necessary infor-
mation for the tomosynthesis reconstruction of the data col-
lected by the Detector Insert.
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The method was tested in a clinical whole-body CT scanner
(Figure 1C). The detector insert was a ﬂat-panel photon-count-
ing detector placed on the patient bed. An acrylic body phantom
that simulated the attenuation of an adult torso was used in all
imaging tests to provide realistic signal levels. Images of reso-
lution targets inside the body phantom resolved 0.2-mm-diam-
eter holes in a square matrix of 0.4-mm pitch in a 0.30-second
scan, in comparison to the 0.5-mm holes/1.0-mm pitch by the
CT scanner alone at the same dose concentration CTDIvol in a
0.6-second scan. Images of a mouse specimen inside the body
phantom were also compared.
Regarding the limitations of this approach, a technical bot-
tleneck is the 400 FPS imaging speed of the ﬂat-panel photon-
counting detector, which is 1/20th the speed of a clinical CT
detector. It meant that image blurring in the lateral direction is
dominated by the movement of the x-ray focal spot. This is
because as the gantry rotates, the travel distance of the focal
spot during the acquisition of a single projection image is
several times the size of the spot. This point was veriﬁed exper-
imentally. Other limitations are inherent to tomosynthesis, in-
cluding out-of-plane shadowing artifacts, an-isotropic image
resolution, and lack of a measure of the absolute CT density in
Hounsﬁeld units.
Looking into the future, while clinical whole-body CT
scanners continually achieve smaller focal spot size and
better detector resolution, focal spot size penumbra continues
to be a limiting factor in system resolution. For example, the
latest photon-counting detectors provide resolutions better
than 50 m (4), while the progress of focal spot size lags
behind, reaching 0.4–0.5 mm, currently at low power set-
tings (https://www.itnonline.com/content/canon-medical-
systems-aquilion-precision-ct-receives-fda-clearance). Therefore,
contact detector inserts (CDIs) should continue to provide an
extra boost of resolution in a targeted rescan of a region of
interest in future whole-body scanners. Future development
directions include more sophisticated and customized image
reconstruction methods for the tomosynthesis rescan, and
faster photon-counting detector inserts to reduce blurring
(C) 
Contact flat panel 
detector insert(s)
acquire images 
simultaneously with 
the CT detector. 
CT detector acquires 
images simultaneously 
with the detector 
inserts. 
patient bed 
(A)
(B) 
Detector insert 
Sample on  
foam spacer 
Body phantom 
patient 
Figure 1. Concept of the contact
detector insert (CDI) and experi-
mental setup. In the schematic of
a hybrid computed tomography
(CT) system, the x-ray tube is
switched on over part of the gan-
try rotation for tomosythesis by the
CDI. The CT detector simultane-
ously acquires data to provide
positional information of the CDI
(A). Estimated x-ray tube focal
spot penumbras at the bore center
for the CDI and the CT detector,
for the Toshiba Aquilion One
Genesis scanner, accounting for
gantry rotation (B). The circle, tri-
angle and diamond mark actual
experiments. Dotted line is for a
hypothetical high-speed detector
insert. Dashed line is for the de-
tector of the CT scanner operating
at high-power/large focal spot
mode. Dash-dotted line is for the
CT scanner operating at low-pow-
er/small focal spot mode, which
is the mode that provided the best
resolution in standard HRCT
scans. The experimental setup
includes an acrylic body phantom
outlined in dashed line, the pho-
ton-counting detector insert, and
various resolution phantoms and
samples (C).
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due to gantry rotation. These will be elaborated in the Dis-
cussion section.
METHODOLOGY
The body phantom was made of solid acrylic (Figure 1C). It
provided a 15-cm path length of attenuation through the
acrylic material for all scans to simulate that of an adult body.
Two resolution phantoms were imaged inside the body
phantom (Figure 1C). The ﬁrst was a 3D printed polymer card of
1 mm thickness (Figure 2A) that contained matrices of air holes
of decreasing diameter and increasing density. The CT attenua-
tion coefﬁcient of the polymer material was 130 HU at 120 kV.
The second, a low-contrast card, was also 3D printed to the same
dimensions, but with the holes ﬁlled with wax. The CT attenu-
ation coefﬁcient of the wax was105 HU, or a 235 HU contrast
from the surrounding polymer.
A mouse specimen was also imaged. The specimen was
ﬁxed in 10% formalin in a centrifuge tube, and the tube was
placed horizontally on the surface of the detector insert, inside
the body phantom.
Both the CDI tomosynthesis scan and the high-resolution
CT scan used the axial (cone beam) mode of the scanner with a
static patient bed, to provide the highest dose concentration for
a given beam collimation and scan time, which maximizes the
signal-to-noise ratio (3).
The contact detector insert was a photon-counting detector
(Xcounter Thor Model, Direct Conversion AB, Danderyd, Sweden)
of 256 2048 pixel matrix and 0.1-mm pixel pitch, 400 frames/s
acquisition rate in a 16-bit mode, and single energy threshold of 25
keV. The CT scanner parameters for the tomosynthesis scan were
axial (cone beam) mode 120 kV/700 mA (large focal spot mode),
1.5 s/turn rotation speed, data acquisition over the top 72° arc of
1.0/2.0 
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0.9/1.8 
0.8/1.6 
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0.5/1.0 
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Figure 2. Comparison of the CT
image and CDI tomosynthesis
images of a resolution card,
taken at the same CTDIvol inside
the body phantom. The tomosyn-
thesis images were taken at vari-
ous sample-to-detector distances.
A picture of the 3D printed reso-
lution card of 1.0 mm of thick-
ness, consisting of matrices of air
holes (A). The labels denote the
hole diameter/center-to-center
spacing of the hole matrices. The
CT scan resolved the 0.5-mm
hole matrix (red box) (B). The CDI
tomosythesis scan resolved the
0.2-mm hole matrix (red box)
when the card was place on the
surface of the detector (15 mm
from the image plane within the
detector) (C). When the resolu-
tion card was elevated to 15 mm
above the detector surface (30
mm from the image plane) with a
foam spacer, the CDI image was
blurred in the horizontal direction
due to focal spot travel over the
image acquisition time, and re-
solved only the 0.2-mm hole ma-
trix vertically (red box) (D). The
resolution card was further ele-
vated to 45 mm above the detec-
tor surface (60 mm from the im-
age plane), and further horizon-
tal blurring was seen due to focal
spot travel (E).
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gantry rotation in 0.3 seconds and 210 mAs, beam collimation of 2
cm and CTDIvol of 15.2 mGy. The image plane within the detector,
which is the semiconductor conversion layer, lies at 14.6mmbelow
the surface of the detector. The resolution cards were placed either
directly on the surface of the detector, corresponding to a distance
of 14.6 mm to the image plane, or on 15- and 45-mm-thick foam
spacers, corresponding to a distance of 29.6 mm and 59.6 mm to
the image plane. A basic ﬁltered back-projection tomosynthesis
image reconstruction was used to reconstruct images at 0.05-mm
pixel size at various depths from the surface of the detector.
For the axial high-resolution CT (HRCT) image acquisition,
the CDI was removed. The resolution cards were positioned in
the axial plane inside the body phantom for best resolution. The
mouse sample was placed directly on the bed of the scanner. All
samples were positioned at the isocenter of the bore. Scan
parameters were axial cone beam mode of 120 kV/350 mA
(small focal spot mode) and 210 mAs (0.6 seconds of rotation
time), beam collimation of 20 0.5 mm (3), and CTDIvol of 15.2
mGy. Images were reconstructed with the FC52 kernel, in-plane
pixel size of 0.25 mm, slice center-to-center spacing of 0.25 mm,
and slice thickness of 0.5 mm. This reconstruction setting was
found to provide the best resolution.
RESULTS
Figure 2, B–E compares the axial HRCT (a-HRCT) and CDI
tomosynthesis images of the high-contrast (1130 HU) resolution
card inside the body phantom, which were acquired at the same
dose concentration (CTDIvol). For the a-HRCT image (Figure 2B),
the reconstruction pixel size of 0.25 mm was found visually to
give the best resolution. The smallest resolved features were the
matrix of 0.5 mm holes. The CDI tomosynthesis image of the
resolution card resolved the 0.2-mm hole matrix when the card
was placed directly on the detector (Figure 2C). When the card
was placed at 15 mm and 45 mm above the detector surface, CDI
tomosynthesis could only resolve the 0.2-mm holes vertically
while they were horizontally burred (Figure 2, D and E). This was
caused by the 6.3-mm travel of the x-ray focal spot over the
acquisition time per frame, which led to a growing lateral pen-
umbra of the focal spot with increasing distance from the de-
tector, as illustrated in Figure 1B.
Figure 3 compares the a-HRCT and CDI tomosynthesis images
of the low-contrast (235 HU) resolution card at the same CTDIvol
level. The a-HRCT image showed some of the 0.9-mm wax dots
(Figure 3A); the CDI tomosynthesis images resolved the matrix of
0.4-mm wax dots (Figure 3B) when the card was placed on the
detector surface or elevated at 45 mm from the surface.
Figure 4 compares the a-HRCT and CDI tomosynthesis images
of the mouse specimen, again at the same dose concentration level.
Two different horizontal sections are shown. The CDI image re-
solved the bone structures at higher resolution such as the individ-
ual ribs, and also visualized structures in the nose and head and the
abdominal cavity which were not visible by a-HRCT.
  
0.4/0.8 
 
0.9/1.8 
(A) 
(B) 
0.9/1.8 
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Figure 3. Comparing CT and
CDI tomosynthesis images of a
low-contrast resolution card ac-
quired at the same CTDIvol inside
the body phantom. The phantom
was a 1.0-mm-thick 3D printed
polymer card with an identical
pattern to the card in Figure 2,
but with the holes ﬁlled with wax
to provide a 235 HU contrast be-
tween the polymer and the wax.
The CT image detected some of
the 0.9-mm diameter holes (red
box). The label is hole diameter/
center-to-center spacing (A). The
CDI tomosythesis image resolved
the 0.4-mm hole array (red box)
when the card was placed on the
surface of the detector (sample-to-
image distance of 15 mm) (B). In
the CDI tomosynthesis image of
the card which was placed at 45
mm above the detector surface
with a foam spacer (sample-to-
image distance of 60 mm), the
same resolution was retained (C).
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DISCUSSION
As a ﬁrst test, this study shows that a contact detector insert in
a whole-body CT scanner achieves ultrahigh resolution in a
0.3-second scan under a realistic level of attenuation by an adult
body, in a zone near the detector. The depth of the zone is
currently limited by the frame rate of the detector. The principle
for high resolution is similar to that of contact radiography, and
the concept in general is similar to surface coils in body MRI,
which provide high sensitivity and resolution near the coils.
When comparing the results of the high- versus low-contrast
resolution cards in the presence of the body phantom attenua-
tion, it was clear that the resolution decreases with lower con-
trast, although the CDI tomosynthesis scan maintains a factor of
two resolution relative to the CT scanner itself at the same dose.
For comparison, a recent Toshiba Aquilion family CT scanner
has an ultrahigh resolution mode of 0.25-mm pixel pitch at the
bore center, which was shown to resolve 0.12-mm-wide slits (1).
However, this was shown in a resolution target alone without the
attenuation of a body phantom, and at 2.4 times the dose concen-
tration of this study (CTDIvol of 36.6 mGy vs 15.2 mGy). More
signiﬁcantly, it required low power output of the x-ray tube to
maintain a smaller focal spot size, leading to scan times of several
seconds compared to the 0.3-second scan of this study. Scan time is
a signiﬁcant factor for ultrahigh resolution, as subtle motion and
drift of the body blur the images over time. Radiation dose is also a
signiﬁcant factor for rescans, as it adds dose onto the standard
scan. Using the dose-length-product (DLP  30.3 mGy*cm) re-
ported by the scanner in this study, we estimate that the added
effective dose of the CDI tomosynthesis rescan in the chest and
abdomen to be 0.42 mSv and 0.45 mSv on average (5), which is
equivalent to 6% of a standard chest or abdomen CT scan (https://
www.radiologyinfo.org/en/info.cfm?pgsafety-xray). This level
of added dose should not impose signiﬁcant burden on the patient,
and it should also allow rescans of several regions in certain cases.
The weakness of the CDI method, as mentioned in the Introduction
section, involves inherent limitations of tomosynthesis, including
out-of-plane shadows, anisotropic resolution, and lack of absolute
CT density measurements.
The mass of the body phantom was mostly on 3 sides of the
resolution targets to simulate the position of the body above the
contact detector insert. This asymmetric disposition did not have
adverse effects on the image quality of the standard CT scans as
long as the resolution targets were positioned at the center of the
bore: the same image quality and resolution were attained when
10mm 
(A) 
(B) 
(C) 
(D) 
Head 
Pelvis 
Tail 
Abdomen 
Figure 4. Comparing CT and
CDI tomosythesis images of a for-
malin-ﬁxed mouse specimen
placed in the body phantom. The
specimen is ﬁxed in formalin in a
centrifuge tube. The same CTDIvol
of 15.2 mGy was used. (A) and
(C) are CT scan coronal sections.
(B) and (D) are the CDI images of
the same locations. The resolution
of the bone structures is higher in
the CDI images; structures in the
nose and head and the abdominal
cavity become visible in the CDI
images.
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compared with the same a-HRCT scans on a standard body
phantom with resolution inserts from a previous study (3).
Further developments are envisioned in both hardware and
software. For software, this study used basic reconstruction
procedures without any artifact reduction measures. A signiﬁ-
cant part of the on-going work is the improvement of the
reconstruction methods in both algorithms and computation
speed. Advanced tomosynthesis reconstruction methods that are
being developed for other applications such as digital breast
tomosynthesis [see reference (7) for a review] may be considered
to see whether they are suitable for this application. Depending
on the location of the region of interest within the body for the
rescan, the inﬂuence of strongly attenuating structures such as
bone and implanted devices may vary widely. Therefore, the
reconstruction method and the placement of the contact detec-
tor insert should be adaptable to the location of the rescan.
For hardware, multiple detectors can be inserted to conform
to the surface of the body for optimal coverage of a targeted
internal region or several regions. The speed of compact photon-
counting detectors is improving and can be expected to match
that of CT detectors in a few years, thereby increasing the depth
of the high-resolution zone as illustrated by the dotted line in
Figure 1B of a hypothetical detector insert of 10,000 fps speed.
A recent development is ﬂexible x-ray detectors of high sensi-
tivity using hybrid organic–inorganic materials (6), which may
lead to contact detector inserts that can bend and conform to the
shape of the body, much like the surface coils of MRI scanners.
Whether using multiple detectors or bendable detectors, the
exact geometry of the detector inserts during each scan need to
be determined for tomosynthesis reconstruction. Therefore, the
simultaneous image acquisition by the CT scanner itself be-
comes indispensable for this purpose.
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Intrarenal hypoxia develops within a few days after the onset of insulinopenic diabetes in an experimental
animal model (ie, a model of type-1 diabetes). Although diabetes-induced hypoxia results in increased renal
lactate formation, mitochondrial function is well maintained, a condition commonly referred to as pseudohy-
poxia. However, the metabolic effects of signiﬁcantly elevated lactate levels remain unclear. We therefore
investigated in diabetic animals the response to acute intrarenal hypoxia in the presence of high renal lac-
tate formation to delineate mechanistic pathways and compare these ﬁndings to healthy control animals. Hy-
perpolarized 13C-MRI and blood oxygenation level–dependent 1H-MRI was used to investigate the renal me-
tabolism of [1-13C]pyruvate and oxygenation following acutely altered oxygen content in the breathing gas
in a streptozotocin rat model of type-1 diabetes with and without insulin treatment and compared with
healthy control rats. The lactate signal in the diabetic kidney was reduced by 12%–16% during hypoxia in
diabetic rats irrespective of insulin supplementation. In contrast, healthy controls displayed the well-known
Pasteur effect manifested as a 10% increased lactate signal following reduction of oxygen in the inspired air. Re-
duced expression of the monocarboxyl transporter-4 may account for altered response to hypoxia in diabetes
with a high intrarenal pyruvate-to-lactate conversion. Reduced intrarenal lactate formation in response to hypoxia
in diabetes shows the existence of a different metabolic phenotype, which is independent of insulin, as insulin
supplementation was unable to affect the pyruvate-to-lactate conversion in the diabetic kidney.
INTRODUCTION
In the diabetic kidney, hyperglycemia activates primarily mito-
chondrial uncoupling and secondarily the production of reac-
tive oxygen species, which reduces energy production and cre-
ates hypoxia and an increased oxygen sensitivity in the kidney
(1-5). Lactate dehydrogenase (LDH) and pyruvate dehydroge-
nase (PDH) are key enzymes in the pyruvate metabolism, thus
facilitating pyruvate conversion to lactate or acetyl coenzyme
A. Acetyl coenzyme A is the entry into Krebs cycle and follows
the mitochondrial respiratory chain. An unchanged PDH activ-
ity indicates sufﬁcient oxygen supply to the diabetic kidney,
while hypoxia causes an elevated lactate pool and possibly a
reduced PDH activity (1, 6, 7).
Magnetic resonance imaging (MRI) is considered an impor-
tant functional imaging method for clinical decision-making in
patients with renal disease (8-11), as well as in preclinical
animal studies (12-15). Particularly important to assess the met-
abolic balance (PDH versus LDH) are the blood oxygenation
level–dependent (BOLD) method and the metabolic imaging
approach referred to as hyperpolarized 13C-based magnetic res-
onance (MR) spectroscopy (5, 16-19). The combination of these
2 methods enables longitudinal assessment of oxygen availabil-
ity in parallel with PDH ([1-13C]pyruvate-to-13C-bicarbonate
conversion) and LDH ([1-13C]pyruvate-to-[1-13C]lactate conver-
sion) ﬂux estimation directly in the kidney tissue in vivo (5).
Previous studies have shown high and unaltered pyruvate-to-
lactate conversion in the early diabetic kidney (3, 5, 20-24). This
pyruvate-to-lactate conversion has previously been correlated
with the severity of diabetic renal complications toward diabetic
nephropathy (25). Interestingly, diabetic rats with similar pyru-
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vate-to-lactate conversion to healthy controls under normoxic
conditions showed an increased pyruvate-to-lactate conversion
following acute reduction in the respired oxygen content (3).
Moreover, treatment with insulin increased the overall meta-
bolic conversion (not sufﬁcient to maintain good glycemic con-
trol), including increased pyruvate-to-lactate conversion (20).
These discrepancies seem to suggest either a large variation in
the streptozotocin model or potential distinct metabolic pheno-
types. In this study, we investigated the metabolism of diabetic
rats exhibiting increased pyruvate-to-lactate conversion com-
pared with previous reports at similar time points and similar
conditions (2 weeks of diabetes), although similar or even less
pronounced diabetic complications and as such represent a
naturally occurring phenotype or variation with unknown ori-
gin. We study the response to acutely altered oxygen supply
[66% O2, sufﬁcient oxygen to ensure fully saturated blood
versus 10% O2, low oxygen content similar to previous report
(3)], with and without insulin supplementation. We test the
hypothesis that severe pseudohypoxia [highly elevated lactate-
to-pyruvate ratio compared with controls and aforementioned
previous reports at 2 weeks (3, 20)] is unable to compensate the
lack of oxygen by increasing the intracellular lactate and thus is
exhibiting an alternative metabolic phenotype.
METHODOLOGY
Animals and Study Protocol
Twenty-two 8-week-old female Wistar rats (N  7–8/group;
Taconic, Ry, Denmark) were included in this study. The rats were
kept in cages with a 12:12-h light–dark cycle, temperature of
21°C 2°C and a humidity of 55% 5%. Diabetes was induced
by an intravenous injection of freshly prepared streptozotocin
(55 mg/kg body weight; Sigma-Aldrich, St. Louis, MO) dissolved
in 10 mmol/L cold citrate buffer (pH 4.5). Blood glucose was
measured in tail capillary blood with a Contour blood glucose
meter (Bayer Diabetes Care, Copenhagen, Denmark). Rats were
considered diabetic when the blood glucose levels exceeded 15
mmol/L at 48 h after injection of streptozotocin. The rats were
divided into a diabetes group and treated group after 1.5 weeks
of diabetes. NPH insulin (Eli Lilly, IN) was administered subcu-
taneous daily for 3 days (1 IU morning and 3 IU afternoon)
before the MRI examination. On the day of the MRI examina-
tion, the rats received 1 IU in the morning 2–4 h before the MRI
scan. The study complied with the guidelines for use and care of
laboratory animals and was approved by the Danish Inspector-
ate of Animal Experiments (License: 2010/561-1938).
Colorimetric Assays
Assays to measure LDH and PDH activity and the absolute
amount of lactate were performed according to manufacturer’s
instructions (Sigma-Aldrich, St. Louis, MO). The assays were
performed on homogenized tissue samples dissolved in buffer
from each of the respective assays, derived from cortical kidney
biopsies. Biopsies were obtained at the time of sacriﬁce and
stored in 80°C. Absorbance was measured in 384 Costar well
plates using a PHERAstar FS microplate reader (BMG Labtech,
Birkerød, Denmark). In a full spectrum test screen, we found that
the optimal wavelength was 662 nm for LDH, PDH, and lactate.
The calculated activities were normalized to protein content
in the kidney sample. Protein content was determined using a
Qubit 3.0 ﬂuorometer (Life Technologies, Thermo Fisher Scien-
tiﬁc, Hvidovre, Denmark).
RNA Extraction and Quantitative Polymerase Chain
Reaction
RNA extraction and qPCR were performed. In brief, total RNA
was isolated using a Nucleospin RNA II kit (Strategene, AH
Diagnostics, Aarhus, Denmark) following manufacturer’s in-
structions. We measured RNA purity and concentration using a
Qubit 3.0 ﬂuorometer (Life Technologies). cDNA synthesis was
performed on 0.5-g RNA with the RevertAid ﬁrst-strand cDNA
synthesis kit following manufacturer’s instructions (Thermo
Fisher Scientiﬁc). Samples for qPCR were prepared using Max-
ima SYBR Green Master Mix following manufacturer’s instruc-
tions (Thermo Fisher Scientiﬁc). The qPCR protocol comprised
40 cycles of denaturation for 30 seconds at 95°C followed by
annealing and synthesis for 1 minute at 60°C. Rat primer se-
quences used are described in Table 1. As mentioned, kidneys
were rapidly dissected after sacriﬁce. Cortex and inner me-
dulla were isolated to tubes and dumped in liquid nitrogen
and stored in 80°C. Cortex biopsies were homogenized for
RNA extraction.
[1-13C]Pyruvate Hyperpolarization
A volume of 20-L [1-13C]pyruvic acid (Sigma Aldrich) con-
taining 15mM OX063 (Oxford Instruments, Oxford, UK) and 1.5
mmol/L Dotarem (Guerbet, Villepinte, France) was inserted into
a dissolution-DNP HyperSense polarizer (Oxford Instruments
Molecular Biotools, Oxford, UK). The sample was polarized for
Table 1. RT-PCR Primer Sequences
Gene Forward Sequence Reverse Sequence
Rat 18S 5=-CAT GGC CGT TCT TAG TTG-3= 5=-CAT GCC AGA GTC TCG TTC-3=
Rat PDH-A1 5=-TCC ACT CCT TGT AGC TGC AAC-3= 5=-GAG AAC CCA CCA CCC CAT G-3=
Rat LDH-A 5=-GCC ATG TAT TCC TTC CCT CA-3= 5=-GCC TCA TTG AAG ACC TGC TC-3=
Rat ALT 5=-GCC ATG TAT TCC TTC CCT CA-3= 5=-GCC TCA TTG AAG ACC TGC TC-3=
Rat MCT-1 5=-CTC TGG GCG CCG CGA GAT AC-3= 5=-CAA CTA CCA CCG CCC AGC CC-3=
Rat MCT-4 5=-CCA GGC CCA CGG CAG GTT TC-3= 5=-GCC ACC GTA GTC ACT GGC CG-3
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1 h at 94.118 GHz (100 mW). The hyperpolarized sample was
dissolved in 4 mL of a dissolution medium (80 mmol/L TRIS, 100
mg/L EDTA, 50 mmol/L NaCl, 80 mmol/L NaOH), yielding an
isotonic 80 mmol/L [1-13C]-pyruvate solution at physiological
pH. The sample temperature after dissolution was 30°C–35°C,
resulting in a reproducible polarization of 30% and a T1 in the
range of 40–60 seconds (26). A volume of 1.0 mL was injected
into the tail vein over 10 seconds. The transfer time between
dissolution and injection was 10 seconds on average, and the
13C chemical shift imaging (CSI) MR-sequence was initiated 20
seconds after start of injection.
Magnetic Resonance Imaging and Spectroscopy
Two weeks after induction of diabetes, tail vein catheterization
was performed for administration of hyperpolarized [1-13C]py-
ruvate. The animal was placed in a 4.7 T Agilent MR scanner
with VnmrJ 4.0 (Agilent, Santa Clara, CA) that was equipped
with a dual-tuned 1H/13C volume transmit and a 4-channel
array surface receive-coil (Rapid Biomedical, Würzburg, Ger-
many). The protocol (Figure 1) consists of 2 baseline scans (1H
BOLD MRI and a 13C magnetic resonance spectroscopy [MRS])
during hyperoxic breathing with 66% oxygen content (0.8%
isoﬂurane, 0.66 L/min oxygen, and 0.34 L/min nitrogen) and 2
postinterventions scans (1H BOLD MRI and a 13C MRS) with a
10% oxygen content (15 minutes of 0.8% isoﬂurane, 0.10 L/min
oxygen, and 0.90 L/min nitrogen). Temperature and respiration
were monitored. After the MRI session, a 5- to 7-mL blood
sample was collected from the aortic bifurcation to EDTA-
coated tubes for determination of plasma electrolytes.
MRI and MRS sequence parameters were as follows. An
oxygenation-dependent (T2*-weighted) sequence was per-
formed using an axial 1H multiecho gradient-echo sequence.
The sequence parameters were: matrix  128  128, ﬁeld of
view (FOV)  60  60 mm2, ﬂip angle  30°, repetition time
(TR)  300 milliseconds, number of transients  16, echo time
(TE)  2, 4, 6, 8, 10, 12, 14, 16 milliseconds, slices  3, slice
thickness  5 mm, covering both kidneys. A scout 1H axial
gradient echo sequence (matrix  128  128, FOV  60  60
mm2, TR/TE  100 ms/2.6 ms, ﬂip angle  20°, averages  16,
slices  7, slice thickness  3 mm, covering both kidneys) was
acquired for anatomical overlay. A slice-selective 2D 13C chem-
ical-shift imaging sequence was used for hyperpolarized [1-
13C]-pyruvate imaging. Parameters were chosen to be similar to
previous studies in the same animal model (4, 20): ﬂip angle 
10°, a centric circular k-space trajectory (169 phase encodings),
TR/TE 75 ms/0.65 ms, FOV 60 60 mm2, spectral width
4000 Hz, data sampling  256 complex points, and an axial
slice thickness  20 mm, covering both kidneys.
MRI Analysis
Data analysis of BOLD MRI data was performed in VnmrJ 4.0,
generating R2* maps. CSI data were processed in Matlab (Math-
Works, Natick, MA). Spatial dimensions were apodized with a
hamming function and zero-ﬁlled to a 32 32 grid. The spectral
dimension was centered on the pyruvate frequency; apodized
with a zero shifted sine-bell function and a 5-Hz exponential
line broadening; and processed as sum-of-squares of the four
coil channels. Spectral analysis was performed on a single voxel
placed inside the kidney. Metabolite signals were integrated
over a 60-Hz symmetric region. The metabolite signals were
normalized relative to the total carbon signal.
Statistical Analyses
Normality was assessed with quantile plots. P  .05 was con-
sidered statistically signiﬁcant. A 2-way repeated measurement
analysis of variance (ANOVA) was used to compare the meta-
bolic response as a function of oxygen availability between the
three groups, using Sidak corrections for multiple comparisons.
Statistical analysis was performed in PRISM. Statistical analysis
of animal, kidney weight and blood glucose were analyzed with
a 1-way ANOVA, while HbA1c between the diabetics and the
diabetics receiving insulin was analyzed using a 2-tailed Stu-
dent t test with equal variance. The intrarenal lactate concen-
tration variance was analyzed using a Brown–Forsyth test of
variance.
RESULTS
All diabetic rats developed sustained hyperglycemia within 48 h.
Body weight, kidney weight, and long-term glucose level HbA1c
were comparable between diabetes and insulin-treated groups
(Table 2). Renal oxygen availability depended on the inspired
oxygen content, and BOLD MRI showed a signiﬁcantly de-
creased T2* in the renal cortex in all groups following a reduc-
tion in the oxygen content of the breathing gas (diabetes group,
diabetes  insulin group, and control group) (P  .001) (Figure
2). The medullary T2* was inversely correlated with oxygen
content in the breathing gas in both the diabetes group (P 
.0009) and in the diabetes  insulin group, albeit the latter did
not reach signiﬁcance (P  .087) (Figure 2). On the other hand,
T2* was unaffected by altered oxygen availability in the control
group (P  .96) (Figure 2). Both untreated diabetic (P  .001)
and insulin-treated diabetic (P  .001) rats had an overall
increased lactate production (lactate-to-total carbon ratio) in
the kidneys compared with healthy controls. In both the
untreated diabetes group (P  .001) and the insulin-treated
diabetes group (P .004), we found a decreased lactate-to-total
carbon ratio in response to decreased oxygen availability, while
the healthy controls (P .035) showed a signiﬁcantly increased
lactate-to-total carbon ratio in response to decreased oxygen
availability (Figure 3). The alanine and the bicarbonate-to-total
carbon ratios were unaffected by altered oxygen supply in all
groups (Figure 3). The pyruvate-to-total carbon ratio increased
after administration of a low oxygen content in the diabetes
group compared with controls (P  .001), and similar ﬁndings
were found in the diabetes  insulin group (P  .001), while a
tendency toward a decreased pyruvate signal was observed in
the diabetes insulin group (P .070) (Figure 3). A statistically
signiﬁcant variance (Brown–Forsyth test, P  .040) was found
in renal lactate concentration among the groups, indicating a
signiﬁcantly elevated lactate concentration in the 2 diabetes
groups compared with controls (Figure 4).
A statistically signiﬁcant difference in lactate dehydroge-
nase activity was found between both diabetes groups and the
control group (P  .001), with the highest activity seen in the
diabetes insulin group, while no difference in LDH expression
was seen between any of the groups (Figure 4). No difference
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Figure 1. Study protocol (A). All animals were exposed to either 66% oxygen content or 10% oxygen content in the breathing
gas. Blood oxygen level–dependent (BOLD) scan is performed 10 minutes after the change of oxygen content followed by a hyper-
polarized 13C pyruvate scan 20 minutes thereafter. Hyperpolarized 13C chemical shift imaging (CSI) image of a healthy control
animal and accompanying kidney spectra from the green region of interest (ROI) (B). Hyperpolarized 13C CSI image of a untreated
diabetic animal and accompanying kidney spectra from the green ROI (C). Hyperpolarized 13C CSI image of an insulin-treated
diabetic animal and accompanying kidney spectra from the green ROI (D).
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was seen in the lactate-to-bicarbonate, lactate-to-alanine, and
alanine-to-bicarbonate ratios in untreated and insulin-treated
diabetic rats during inspiration of 66% and 10% oxygen in the
breathing gas (Figure 5). The pyruvate dehydrogenase activity
increased in the untreated diabetes group, while the PDH
expression was signiﬁcantly decreased in both diabetes
groups (Figure 6). Monocarboxylate transporters (MCT1) was
found to be similar in all groups (P .27), whereas MCT4 was
found to be signiﬁcantly reduced in both diabetes groups
(P  .001) (Figure 6).
DISCUSSION
We have previously reported that the diabetic kidney responded
with a pronounced increase in lactate formation following re-
duced oxygen availability compared with healthy controls (3).
The decreased lactate formation in response to low oxygen
availability observed in the present study is likely explained by
the severity of diabetic nephropathy and the more increased
lactate level (80% increased pyruvate-to-lactate conversion
compared with previous reports (3, 20). The underlying mech-
anism for this altered metabolic phenotype is believed to
originate from the altered expression of MCT4 in the diabetic
rat kidney (dramatically downregulated) in response to pro-
found lactate accumulation similar to what is observed in
response to prolonged hypoxia (27). MCT1 controls the inﬂux
of lactate, whereas MCT4 ensures redox balance by export of
lactate. Restricting lactic acid efﬂux from renal cells (main-
tained or reduced MCT4 expression) in concern with in-
creased intracellular lactic acid accumulation, leading to an
increased hyperpolarized [1-13C]pyruvate-to-[1-13C]lactate
conversion (increased MCT1 expression in diabetes), might be
a preventive mechanism to avoid systemic lactic acidosis, as
seen in muscles, where an intracellular accumulation of lactic
acid and subsequent altered redox state will inhibit glycolysis
and induce muscle fatigue before systemic alterations to the
pH regulation of the body (27, 28). Indeed mild acidosis has
recently been associated with an altered metabolic phenotype in
postmitotic cells, overriding oxygen deprivation and thus main-
taining mitochondrial function (29). Taken together, an altered
MCT transport is essential to the metabolic phenotype seen in
diabetes, and an altered efﬂux of lactate could be the origin of this
counterintuitive oxygen reversed oxygen sensitivity.
Table 2. Animal Characteristics
Body Weight
(g)
Kidney Weight
(g)
Blood Glucose
(mmol/L) HbA1c (%)
Control 222  7 0.8  0.1 8.6  0.7 Not measured
Diabetes 213  20 1.1  0.1a 23.8  3.8a 11.4  1.5
Diabetes  Insulin 200  26 1.1  0.2a 21.0  4.0a 12.3  0.7
aP  0.05 versus control. The blood glucose level is the average blood glucose of the 2 measurements performed in each rat. Values are represented as mean  SD.
Comparisons analyzed using 1-way ANOVA and Student t test.
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Figure 2. BOLD magnetic resonance imaging (MRI) in cortex and medulla of controls and untreated and insulin-treated
diabetic rats during inspiration of 66% and 10% oxygen in the breathing gas. (Cortical T2*) P  .68 for group (be-
tween healthy controls and untreated and insulin-treated diabetic rats), P  .0001* for treatment (inspired oxygen), and
P  .81 for interaction (A). (Medullary T2*) P  .08 for group (between healthy controls and untreated and insulin-
treated diabetic rats), P  .005* for treatment (Inspired oxygen), and P  .04 for interaction* (B). Lines denote mean 
SEM. Two-way repeated ANOVA.
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Figure 3. Hyperpolarized lac-
tate, pyruvate, alanine, and bicar-
bonate signal to sum of the signal
ratios in controls and untreated
and insulin-treated diabetic rats
during inspiration of 66% and
10% oxygen in the inspired air.
(Lactate-to-signal) P  .001
for group* (between healthy con-
trols and untreated and insulin-
treated diabetic rats), P  .002*
for treatment (inspired oxygen),
and P  .0007 for interaction*
(A). (Alanine-to-signal) P 
.43 for group (between healthy
controls and untreated and insulin-
treated diabetic rats), P  .15 for
treatment (inspired oxygen), and
P  .6 for interaction (B). (Pyru-
vate-to-signal) P  .001 for
group* (between healthy controls
and untreated and insulin-treated
diabetic rats), P  .002 for treat-
ment* (inspired oxygen), and P 
.05 for interaction* (C); (Bicar-
bonate-to-signal) P  .1 for
group* (between healthy controls
and untreated and insulin-treated
diabetic rats), P  .85 for treat-
ment* (inspired oxygen), and P 
.46 for interaction. Two-way re-
peated ANOVA (D).
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Figure 4. Colorimetric assay lactate dehydrogenase activity (P  .001) (A), qPCR lactate dehydrogenase mRNA ex-
pression (P  .787) (B), and colorimetric assay kidney tissue lactate concentration (P  .187) (C); signiﬁcant variance
(Brown–Forsyth test, P  .04) was found between healthy controls and untreated and insulin-treated diabetic rats. One-
way ANOVA.
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We speculate that the altered lactate transport could be
active inhibition of the monocarboxylic transporters, as previ-
ously shown for the active mitochondrial pyruvate transporter
with -cyano-4-hydroxycinnamate (30) and in muscle tissue
where lactate uptake and efﬂux stimulate an increased lactate
concentration and altered intra- and extracellular pH (31).
Interestingly, the increased lactate-to-total carbon ratio in
the diabetic kidney occurred regardless of insulin supplementa-
tion, indicating that insulin did not affect the balance between
oxygen availability and energy metabolism in the hypoxic dia-
betic kidney. These ﬁndings support previous reports on in-
creased lactate production in the diabetic kidneys regardless of
Figure 5. Hyperpolarized lactate-to-bicarbonate, lactate-to-alanine, and alanine-to-bicarbonate signal ratios in un-
treated and insulin-treated diabetic rats during inspiration of 66% and 10% oxygen in the inspired air. (Lactate-to-
Bicarbonate) P  .73 for group (between healthy controls and untreated and insulin-treated diabetic rats), P  .98 for
treatment (inspired oxygen), and P  .06 for interaction (A). (Lactate-to-Alanine) P  .14 for group (between
healthy controls and untreated and insulin-treated diabetic rats), P  .78 for treatment (inspired oxygen), and P  .12
for interaction (B). (Alanine-to-bicarbonate) P  .32 for group (between healthy controls and untreated and insulin-
treated diabetic rats), P  .72 for treatment (Inspired oxygen), and P  .23 for interaction (C). Two-way repeated
ANOVA.
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Figure 6. (A) Colorimetric assay
pyruvate dehydrogenase activity
and (B) qPCR mRNA expressions
of pyruvate dehydrogenase; com-
parison of (C) monocarboxylate
transporter 1 (MCT1) and (D) 4
(MCT4) in healthy controls and
untreated and insulin-treated dia-
betics rats. One-way ANOVA.
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insulin treatment (20). However, these results also imply the
presence of different metabolic phenotypes occurring in diabe-
tes, as high intrarenal lactate levels signiﬁcantly altered the
response to reduced oxygen availability in the diabetic animals
(3, 4, 20, 25). This ﬁnding might be explained by the need for the
high lactate-producing kidney to maintain homeostasis during
hypoxia as previously reported in cancer cells (32). Thus, acute
hypoxia in an already high lactate environment increases the
lactate-to-pyruvate conversion and/or reduces the pyruvate-to-
lactate conversion and thus maintains the intracellular redox
potential. It is unlikely that the difference in the metabolic
conversion is due to decreased conversion in diabetic rats, as the
pyruvate-to-total carbon ratio was lower (ie, more pyruvate is
being converted to its metabolic derivatives) in diabetics com-
pared with controls.
The increased pyruvate-to-lactate conversion may charac-
terize the severity of the deranged metabolism in the diabetic
kidney, as previously described by Lin et al. (33). However, the
increased lactate-to-pyruvate level found in the diabetic kidney
in this study was not directly linked to severity, and thus, the
altered response to oxygen supply may enable a further differ-
entiation of the metabolic phenotype by interrogating the un-
derlying mechanism, thus providing a window of opportunity
for pharmacologically targeting these metabolically different
phenotypes. In fact, recent studies have indicated that increased
glycolytic ﬂux as a renal protective trait and thus the phenotype
seen here might be better protected against renal impairment
(34). The alanine-to-total carbon ratio, regulated by the alanine
transferase and linked via the cosubstrate glutamate and -ke-
toglutarate to the glutamine and fatty acid synthesis, is insen-
sitive to the changes in inhaled oxygen. This lack of oxygen
dependency indicates a generally sufﬁcient oxygen availability
to maintain the increased mitochondrial fatty acid oxidation in
kidney tubular cells (35) and similarly the bicarbonate-to-total
carbon ratio that describes the oxidative phosphorylation via
the mitochondrial pyruvate dehydrogenase activity (2-4). The
oxygen-sensitive BOLD MRI showed hypoxia and increased
oxygen consumption. These measurements indicate that a gen-
eral deranged metabolism is inversely dependent on oxygen
availability in the severe pseudohypoxic diabetic kidney, both
with and without insulin treatment. Therefore, we suggest that
the sensitivity toward changes in oxygen supply deﬁnes an
alternative diabetic phenotype, indicating reduction in active
cellular uptake of pyruvate. A potential limitation in the study
design is the use of CSI for spatial localization of the metabo-
lites, limiting the spatial resolution and especially the temporal
resolution compared with faster or higher resolution imaging
methods (26, 36-39). Another limitation is the need for anes-
thetics, which have been shown to impact the renal metabolism
(40), although the used regime has only mild renal effects com-
pared with other anesthetic regimes. Insulin administration did
not alter the overall metabolic phenotype, which is supported by
previous studies in heart and kidneys (20, 41, 42). However, it is
important to note that the used insulin treatment was a dose
mimicking suboptimal insulin treatment similar to a previous
report (20), and as such, it is currently unknown what the impact
of adequate insulin administration for sufﬁcient glycemic con-
trol would entail. Further, 66% oxygen was chosen to ensure
fully saturated blood, thus maximizing the potential differences
between hypoxia and hyperoxia. No difference was observed
between the results of this study in healthy controls and previ-
ous reports in controls and diabetics under normoxia and hy-
peroxia (100%) (3), and thus, it is unlikely that hyperoxia (66%
O2 in inspired air) was signiﬁcantly contributing to the higher
lactate production seen in the diabetic rats. Hyperglycemia-
induced ketosis could be another potential confounding factor
in the metabolic phenotypes, although rarely seen in the animal
model used in this study (43); individual metabolic states could
be a contributing factor in the increased variance seen in the
diabetic rats.
In conclusion, the altered metabolic phenotype, manifested
as signiﬁcantly altered oxygen sensitivity in the presence of
high intrarenal lactate levels, shows the existence of two seem-
ingly different metabolic phenotypes in the diabetic kidney,
which may highlight the need for tailored treatment strategies to
reduce the impact of diabetes on long-term kidney function.
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Matrix gradient coils with up to 84 coil elements were recently introduced for magnetic resonance imaging.
Ideally, each element is driven by a dedicated ampliﬁer, which may be technically and ﬁnancially infeasible.
Instead, several elements can be connected in series (called a “cluster”) and driven by a single ampliﬁer. In
previous works, a set of clusters, called a “conﬁguration,” was sought to approximate a target ﬁeld shape.
Because a magnetic resonance pulse sequence requires several distinct ﬁeld shapes, a mechanism to switch
between conﬁgurations is needed. This can be achieved by a hypothetical switching circuit connecting all
terminals of all elements with each other and with the ampliﬁers. For a predeﬁned set of conﬁgurations, a
switching circuit can be designed to require only a limited amount of switches. Here we introduce an algo-
rithm to minimize the number of switches without affecting the ability of the conﬁgurations to accurately cre-
ate the desired ﬁelds. The problem is modeled using graph theory and split into 2 sequential combinatorial
optimization problems that are solved using simulated annealing. For the investigated cases, the results show
that compared to unoptimized switching circuits, the reduction of switches in optimized circuits ranges from
8% to up to 44% (average of 31%). This substantial reduction is achieved without impeding circuit function-
ality. This study shows how technical effort associated with implementation and operation of a matrix gradi-
ent coil is related to different hardware setups and how to reduce this effort.
INTRODUCTION
Recently, matrix gradient coils (also termed multi-coils or multi-
coil arrays) were introduced for both magnetic resonance image
acquisition and B0 shimming (1-6). Almost 2 decades earlier, a
similar concept called matrix shim coil system was introduced
for nuclear magnetic resonance (7). Such coils consist of a
multitude of (up to 84) compact coil elements, which are in the
most trivial conﬁguration individually supplied by a current
ampliﬁer. The created ﬁeld is a superposition of the ﬁelds pro-
duced by individual coil elements. This multiple-coil topology
allows for the creation of a large variety of different ﬁeld shapes
by adjusting the currents in the individual coil elements. The use
of multiple coils has certain advantages over that of conven-
tional gradient coils and it opens up new possibilities to imaging
and shimming. In most realizations, coil elements of a matrix
gradient coil are smaller than typical dimensions of conven-
tional gradient coils, which allows for faster switching of cur-
rents. One problem associated with conventional linear gradient
coils is the requirement of highly linear ﬁelds across the entire
ﬁeld of view (FOV). With matrix gradient coils, encoding ﬁelds
can be adapted to the actual FOV needed for the given imaging
application. This may potentially be more accurate and/or more
efﬁcient (4), particularly for small FOVs.
Matrix gradient coils are furthermore favorable for nonlin-
ear spatial encoding schemes such as PatLoc (8-15), O-Space
(16-19), or FRONSAC (20). Imaging techniques that incorporate
nonlinear gradients into the magnetic resonance pulse sequence
can utilize the matrix gradient coil’s ability to create a wide
variety of ﬁeld shapes whose nonlinearity extends way beyond
that of the quadratic ﬁelds used in previous work. For magnetic
resonance imaging applications that focus on local anatomy,
nonlinear gradients allow for fast sequences that produce high-
resolution images in a target area and low-resolution images
everywhere else (13). Example images acquired with a matrix
gradient coil can be found in Littin et al.’s study (2), but owing
to the novelty of the concept, many topics mentioned above
require further research and have not made it into clinical
applications yet.
Design strategies for unconventional gradient coils are still
a topic of active research. For classical linear gradients, the
entire gradient system is typically split into 3 gradient channels
that correspond to principal spatial directions X, Y, and Z. Each
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independently driven channel lies on a separate surface within
the gradient coil structure and is designed mostly independent
of the other channels. Variations of the target ﬁeld method
(21-23) are typically used combined with modern numerical
optimization techniques, allowing for a simultaneous control of
the manufacturing constraints such as minimal conductor spac-
ing, electrical characteristics such as coil inductance, resistance
and minimal mutual coupling, as well as ﬁdelity of the achieved
ﬁeld proﬁles. Less conventional gradient system concepts pur-
sue different design strategies, typically including multiple
steps. For example, a linear Z gradient coil with a dynamically
movable imaging region (24) was realized by designing a mul-
titude of current density patterns for varying FOV offsets, fol-
lowed by a singular value decomposition step to compress these
current densities into 3 electrical channels to be controlled by
individual gradient ampliﬁers. In contrast to the aforementioned
design strategies, when designing a matrix coil, the target ﬁeld
or set of ﬁelds is in general unknown. One strategy to address
this challenge is to split the poorly deﬁned and computationally
intractable problem into a set of smaller tractable problems. For
the matrix coil in Littin et al.’s study (2), these steps included the
following:
1. deﬁnition of the number of elements to balance the
ﬁeld strength and ﬂexibility against power dissipation
(25),
2. optimization of the geometry and winding patterns of
individual elements to achieve maximum gradient
strength and sufﬁcient shielding (6),
3. obtaining a method to drive the matrix gradient coil
with substantially fewer ampliﬁers than coil elements
by assigning several coil elements to each of the am-
pliﬁers (called a conﬁguration) while preserving the
matrix gradient coils’ ability to accurately create a
certain ﬁeld shape for a given application (26),
4. ﬁnding a suitable strategy to switch between different
conﬁgurations obtained by step 3 within an imaging
pulse sequence or between the pulse sequences for
different applications or imaging regions,
5. ﬁnding excitation (27), signal conditioning (28), and
sampling (15) strategies that optimally use the ﬂexibil-
ity provided by the matrix coil.
Although the latter task does not strictly belong to the coil
design, it provides the initial motivation as well as the valuable
feedback to the entire chain, and in particular to step 4, as the
different imaging applications mentioned demand for switching
between several varying ﬁeld shapes. The present paper con-
cerns itself primarily with step 4 from the above listing and
builds on top of step 3 which was addressed in previous work
(26).
Although the matrix gradient coil design in (2) aimed at
maximum ﬂexibility in creating a wide variety of ﬁeld shapes to
assess the advantages and disadvantages of this approach, fu-
ture coils could be speciﬁcally designed for a certain range of
applications or use cases. One example for a matrix gradient coil
speciﬁcally designed for high gradient strength with acceptable
switching rates, as required for high b-factor diffusion imaging,
are the linear gradient coils of the Human Connectome Project
(29), which use 4 independent coil elements per linear gradient
axis and are driven by a total of 12 ampliﬁers. Apart from
imaging, matrix coils or multi-coils can be used for B0 shimming
and both imaging and B0 shimming at the same time (30).
Although shimming requires only low current and therefore
relatively low-cost power supplies, encoding requires substan-
tial currents, which necessitates powerful and therefore expen-
sive ampliﬁers. For shimming, each coil element can be driven
by an individual ampliﬁer (4, 3), but for imaging applications,
which is the focus of this work, it is desirable to keep the number
of ampliﬁers as low as possible.
In an earlier work (26), we presented a method to use the
matrix gradient coil with fewer ampliﬁers than coil elements.
When using fewer ampliﬁers than coil elements, the coil ele-
ments are distributed over the available ampliﬁers such that
several coil elements are assigned to a single ampliﬁer. All coil
elements assigned to a certain ampliﬁer are connected in series
and supplied with the same current from the corresponding
ampliﬁer. The coil elements assigned to a single ampliﬁer are
termed a cluster, and a set of NA clusters is called a conﬁgura-
tion, where the number of ampliﬁers is deﬁned as NA. In our
previous work, we have shown how such a conﬁguration can be
optimized by assigning coil elements to clusters such that a
desired target ﬁeld shape can be approximated with high accu-
racy. We have shown that this combinatorial optimization prob-
lem can be solved such that even with a reduced number of
ampliﬁers, a large range of ﬁeld shapes can be created accu-
rately. For instance, for an 84-channel coil and only 12 ampli-
ﬁers, it was possible to create spherical harmonics up to third
order with a median normalized least squares error of 	5%.
With 24 ampliﬁers, the median normalized least squares error
reduces to 
2.5%, while it increases to 
10% for 6 ampliﬁers.
Note that a conﬁguration creates the desired target ﬁeld with a
particular ratio of the currents supplied by the ampliﬁers. In
principle, this restriction can be lifted by changing the ratio to
create a wide range of different ﬁeld shapes with a single
conﬁguration. This means that in practice, each conﬁguration is
more powerful than what it was optimized for; however, exploi-
tation of this degree of freedom requires further investigation in
future work. Details of the implementation and the performance
analysis of the solver are presented in Kroboth et al. (26, 31). In
Kroboth et al.’s study (26), each conﬁguration was optimized to
create a single target ﬁeld; however, typical imaging applica-
tions require the application of several distinct encoding ﬁelds,
where each generally corresponds to a different conﬁguration.
Different encoding ﬁelds usually require different conﬁgura-
tions; therefore, to switch between encoding ﬁelds, a mechanism
is required to switch between conﬁgurations. Essentially, this
means opening and closing connections between coil elements,
depending on the requirements of the desired conﬁguration.
This can be achieved via a so-called switching circuit (32), which
can be cast into the epoxy resin together with the matrix gra-
dient coil. If space limitations become a problem, the circuit can
be located outside the coil. An example of such an approach,
which relies on a dense switching network, was proposed re-
cently for B0 shimming and is termed dynamically controlled
adaptive current network (33). In such a network—owing to a
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particularly simple geometry of the B0-contributing elements,
which are straight wire segments orthogonal to the B0 direc-
tion—a 2D network of metal–oxide–semiconductor ﬁeld-effect
transistor (MOSFET) switches connecting each element to its
neighbors and a single ampliﬁer is sufﬁcient to realize any
discrete current path. However, the achievable surface current
density in such a network is not sufﬁcient for imaging applica-
tions requiring strong local gradients. Therefore in our research,
we focus on multiturn element geometries. A switching circuit
for the available 84-element matrix gradient coil, in its straight-
forward implementation, can be designed to connect every ter-
minal of a coil element to all terminals of every other coil
element. In addition, every terminal of each coil element has to
be connected with every terminal of every ampliﬁer. This hypo-
thetical switching circuit would allow for arbitrary current paths
through a network of coil elements. By changing the state of the
individual switches, every conﬁguration can be realized, allowing
for sequences such as the one illustrated in Figure 1, where the
conﬁguration for the next encoding ﬁeld can be switched at zero-
current conditions. Unfortunately, this would require 18 060
switches for the case of NC  84 coil elements and NA  12
ampliﬁers, as the number of switches necessary to connect all coil
element terminals to each other is given byNC · (2 ·NC 1) 14028,
and the number of switches necessary to connect all ampliﬁer
terminals to all coil element terminals is given as
4 · NC · NA 4032. Not only is this technically infeasible owing
to the complexity of the network and the dimensions of the
individual switches, it is also potentially prohibitively expensive
owing to the requirements on the switches (high currents, fast
switching times). In this work we use the property that if a ﬁnite
set of conﬁgurations to be switched is known a priori, a full
switching circuit is not necessary. For instance, connections that
are connected in all conﬁgurations can be hard-wired (no switch
required), and connections that are not present in any conﬁgu-
ration do not require a switch (and no hard-wiring). Only con-
nections that are closed in some but not all conﬁgurations
require a switch. The same applies to the switches that connect
the ampliﬁers to the coil element network. The number of
required switches depends on the conﬁgurations and the order-
ing of elements within a cluster. There are numerous switching
circuits for a given set of conﬁgurations that are all capable of
switching between the conﬁgurations.
We propose an optimization algorithm that ﬁnds, in the set
of all possible switching circuits, one which requires a low
number of switches for a given set of conﬁgurations. We exploit
the fact that the ordering of coil elements within a cluster does
not change its electromagnetic properties owing to the fact that
the elements are connected in series and that any ampliﬁer can
supply any cluster (assuming that the ampliﬁers have equal
speciﬁcations). In our model, the coil elements are characterized
Figure 1. A potential pulse se-
quence with 3 distinct target ﬁelds
T1, T2, and T3, each created by
a corresponding conﬁguration
consisting of NC coil elements
and driven by NA ampliﬁers
(where the ratio of all currents is
predeﬁned). Because conﬁgura-
tions differ for different target
ﬁelds, the sequence requires a
mechanism to switch between dif-
ferent conﬁgurations. This can be
achieved with a switching circuit.
Changing the state of the switches
requires 10 s. This example
shows 3 target ﬁelds; however,
the number (and shape) of the
target ﬁelds can be arbitrary.
Note that by changing the ratio of
the currents supplied to the indi-
vidual clusters, other target ﬁelds
can be created, which were not
part of the optimization process of
the conﬁgurations. Therefore, the
actual capabilities of such a setup
are much larger than this ﬁgure
may suggest at a ﬁrst glance.
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by individual resistances and an inductance matrix and we
further assume perfect switches. The conﬁgurations are de-
signed before the optimization of the switching circuit, for
instance, by the method introduced in Kroboth et al.’s study (26).
Note that the optimization procedure presented in this work does
not affect the magnetic ﬁeld created by the given conﬁguration.
The coil design (2) used in this work is a cylindrical head-insert
with a length of 70 cm and an inner diameter of 39 cm. It
consists of 84 coil elements (6), distributed on 7 rings with 12
elements each (Figure 2A). In line with a previously published
work (26), we assume that each coil element is equipped with a
bridge consisting of 4 switches (Figure 2B). This allows for the
current to be routed through the coil winding in both directions.
Throughout this work, we treat the bridge as an integral part of
each coil element. The method presented here is also applicable
to other matrix gradient coil or multi-coil designs. Ideally, the
problem presented in this work would be optimized jointly with
the optimization of the conﬁgurations. However, as both prob-
lems are combinatorial and as the joint optimization would have
multiple objectives, this was considered intractable given the
currently available computational power.
METHODOLOGY
Theory
Minimizing the number of switches for a given set of conﬁg-
urations can be split into 2 combinatorial NP-hard (non-
deterministic polynomial-time hardness) optimization rou-
tines which are executed sequentially. The ﬁrst minimizes the
number of switches between coil element terminals, then,
based on the result, the second minimizes the number of
switches which connect the ampliﬁers to the matrix coil. The
used variables are summarized in Table 1.
Minimizing the Number of Switches Between Coil Elements.
The problem of reducing the number of switches between the
elements is a distant relative of the well-known traveling sales-
man problem (TSP) (34), where a salesman aims at visiting
several cities in minimum time or minimum travelled distance.
However, here we have NF companies (conﬁgurations Ck, where
k  1, . . ., NF), each employing NA salesmen (ampliﬁers). Each
company assigns NC cities (coil elements) to its salesmen such
that all cities are assigned and every city is assigned exactly
once for each company. Given such a setup, the aim is to ﬁnd a
path for each salesman such that the total number of streets
(connections) between cities (coil elements) and the number of
necessary junctions (switches) are minimal.
A conﬁguration deﬁnes how coil elements are grouped into
clusters. Each cluster is a set of coil elements that are all supplied
with the same current. When implementing a conﬁguration, all
coil elements of a cluster are therefore connected in series in an
arbitrary order and supplied with current by a single ampliﬁer.
For each conﬁguration, there is a graph that models how coil
elements are connected. The ordering of elements within a
cluster does not change the electromagnetic properties of the
cluster (and hence the conﬁguration); however, ordering does
change the associated graph. This means that changes to the
ordering do not affect the ability of the conﬁguration to create a
certain target ﬁeld at a certain accuracy and ﬁeld strength. Let
Ck be the kth of NF conﬁgurations, which is optimized to create
a certain target ﬁeld Tk. Furthermore, let X be a variable that
indicates how coil elements within the clusters are ordered for
all k. Then there is an associated adjacency matrix A(Ck, X) that
indicates which terminals of the coil elements are connected
with each other for the conﬁguration Ck given the ordering X.
The adjacency matrix contains the terminals of the coil ele-
ments, which allows us to account for polarity. Therefore, the
size of A(Ck, X) is 2NC  2NC. Furthermore, let (X, G) be the
sum of a set of NF general adjacency matrices G(Ck, X):
(X, G)
k1
NF
G(Ck, X). (1)
The nonzero entries of (X, G) indicate connections. Let
i,jX, G be the element of (X, G) in the ith row and the jth
column. Every entry where i,jX, G NF indicates a hardwired
connection because this connection exists for every conﬁgura-
tion in case of the ordering X; therefore, there is also no switch
required. Finally, the number of necessary switches is given by
the following equation:
s((X, G))
i,j;j	i
0 if i,j(X, G) 00 if i,j(X, G) NF
1 else
. (2)
Applying equation (2) to the adjacency matrices A(Ck, X) serves
as the cost function for the optimization problem as follows:
X* argmin
X
{s((X, G))}. (3)
For optimization, the following degrees of freedom can be ex-
ploited, which are reﬂected in X:
• The order in which the elements are connected within a
cluster can be arbitrary.
• Each element is equipped with a bridge consisting of 4
switches that allow current to be routed through the ele-
ment in both directions (Figure 2B). Hence every element
can be connected in both orientations provided the current
direction in the coil windings is adapted accordingly by
using the bridge switches.
To change X, either the ordering of elements within a cluster can
be changed or the direction in which a coil element is connected.
Changing X affects the individual adjacency matrices A(Ck, X),
which furthermore affects s((X, A)).
Figure 3 illustrates this principle using a toy example with a
matrix gradient coil with NC  4 coil elements (E1, E2, E3, E4),
NA  2 ampliﬁers, and NF  3 conﬁgurations.
Minimizing the Number of Switches from the Ampliﬁers to the
Coil Element Network. Once a favorable ordering of coil ele-
ments is obtained, the number of necessary switches from the
terminals of the ampliﬁer to the entry and exit terminals of the
individual clusters of all conﬁgurations can be minimized. Let
B(Ck, Y) be adjacency matrices that indicate the connections
between ampliﬁers and clusters of conﬁguration Ck given Y that
deﬁnes which ampliﬁer is assigned to which cluster. Using
equations (1) and (2) with the adjacency matrices B(Ck, Y), the
global optimizer Y * can be obtained via the following equation:
Y * argmin
Y
{s((Y, B))}. (4)
Under the assumption that all ampliﬁers have equal properties
and that they can adapt to the actual load, it is irrelevant which
cluster is driven by which ampliﬁer. Furthermore, the positive
and negative terminals of the ampliﬁer can be connected to
either the entry- or exit-terminal of a cluster because the am-
Switching Circuit Optimization
TOMOGRAPHY.ORG | VOLUME 5 NUMBER 2 | JUNE 2019 251
pliﬁers are bipolar and therefore the direction of the current can
be changed. These degrees of freedom are exploited to minimize
the number of switches that connect the ampliﬁers to the coil
element network. The concept is illustrated in Figure 4, where
changing how ampliﬁers are assigned to the network of coil
elements leads to an ordering that requires 2 fewer switches.
Matrix Gradient Coil and Other Hardware
The algorithm is applied to the matrix gradient coil design
introduced in Littin et al.’s study (2). The gradient coil design
dictates the basic conditions for optimization such as the num-
ber of coil elements; however, in principle, the presented method
can be applied to any matrix gradient coil or multi-coil design.
For the given coil, eddy currents are 1% of the original ﬁeld
owing to the use of Litz wire, shielded element design, and a
substantial distance to the cryovessel. They can therefore be
ignored for most applications. Mutual coupling has been as-
sessed in Littin et al.’s study (2). Both eddy currents and mutual
coupling are ignored in the present work because they are not
affected by any of the operations performed during the optimi-
zation. The ampliﬁers further impose restrictions, owing to the
limitations regarding the load. This is considered via the maxi-
mum and minimum number of coil elements per ampliﬁer in the
optimization of the conﬁgurations as shown in Kroboth et al.’s
study (26). The ampliﬁers used to drive the matrix gradient coil
can be adapted to load changes. Therefore the ampliﬁers need to
A
B
Figure 2. Implementation of the matrix gradient
coil shown at the backside of a Siemens Trio scan-
ner (A). To conduct measurements, the coil is
pushed into the isocenter of the scanner. The black
connections feed current to the individual coil ele-
ments. The water cooling is supplied by the red and
blue hoses. On the side of cart are connector
boards with connections for every coil element. A
schematic representation of a coil element E which
consists of the coil windings L equipped with a
bridge switch (B). This allows to route current
through the element in both directions. One direc-
tion is achieved by having the switches S1 and S3 in
on-state and S2 and S4 in off-state. The other direc-
tion is achieved the other way around. In addition,
the bypass mode can be achieved by having control
switches S1 and S4 in on-state and switches S2 and
S3 in off-state, or the other way around.
Table 1. List of Variables
Variable Explanation
E1 Coil element 1
S1 Switch 1
Amp1 Ampliﬁer 1
p1
2 Terminal 2 of coil element E1
NA Number of ampliﬁers
NC Number of coil elements
NF Number of ﬁelds
ND Number of different (random) conﬁgurations
NR Number of repetitions (optimization algorithm
runs)
Tk Target ﬁeld k
Ck Conﬁguration k
X, Y Orderings
G(Ck, X) General adjacency matrix for a conﬁguration
Ck and an ordering X
A(Ck, X) Adjacency matrix for the connections between
coil element terminals
B(Ck, Y) Adjacency matrix for the connections between
coil element terminals and ampliﬁer
terminals
(X, G) Sum of adjacency matrices
i,jX, G Element (i, j) of sum of adjacency matrices
(X, G)
s((X, G)) Number of switches for (X, G)
Ti Temperature at iteration i (Simulated
Annealing)
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AB
Figure 3. (A) Illustration of how changing the ordering of coil elements within a cluster can affect the number of
switches for a matrix gradient coil with 4 coil elements (E1, E2, E3, E4; each box represents a circuit as shown in
Figure 2B), 2 ampliﬁers (Amp1, Amp2), and NF  3 conﬁgurations (C1, C2, C3). (B) The initial ordering X1 and the up-
dated ordering X2 are shown in the left and right columns, respectively. The ﬁrst 3 rows show how the coil elements are
assigned to and supplied by ampliﬁers to create the NF target ﬁelds. The fourth row summarizes all connections between
coil elements for each setup. Terminals are labeled with the symbol p. Observe that in C1 the ordering of E1 and E2
changes in the ﬁrst cluster, whereas in C2 the ordering of E1, E2, E4 changes to E2, E1, E4. Conﬁguration C3 remains
unchanged. As can be seen in the last row, X1 has only 1 connection between terminals which is used by 2 conﬁgura-
tions, whereas X2 has 2 shared connections. While the ordering X1 requires 5 switches, the ordering X2 requires only 4
switches. Corresponding adjacency matrices of the undirected graph representing 2 conﬁgurations, X1 (top) and X2 (bot-
tom). Each nonzero entry represents a connection between 2 terminals of the coil elements. Applying equation (2) to
each of the 2 adjacency matrices (X1; A) and (X2; A) gives the ﬁnal number of switches, which is 5 for X1 and 4 for X2.
Similar strategies can be followed for the switches connecting the ampliﬁers to the coil element network (Figure 4).
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be reprogrammed whenever the load changes during switching.
Switching is performed at zero current conditions only (32).
Algorithm
The optimization problems addressed in this work [equations (3)
and (4)] are combinatorial and NP-hard. Performing an exhaus-
tive search over the parameter space is too expensive for prac-
tical use. For instance, consider the optimization of a switching
circuit that is designed to switch between 3 conﬁgurations given
a 84-channel coil and 12 ampliﬁers (where for simplicity, the
coil elements are equally distributed amongst the ampliﬁers).
This would require the evaluation of (((84/12)!)12)3 
 2·10133
different orderings for the minimization of the number of
switches in between coil terminals alone. This number is given
by (84/12)!  7! possible orderings of coil elements within a
single cluster to the power of the number of clusters/ampliﬁers
(NA 12) and ﬁnally to the power of the number of ﬁelds (NF
3). This calculation does not even consider the bridge switches,
which would further increase the number of necessary evalua-
tions. The additional complexity owing to the nonconvex and
multimodal (many local minima) nature of the optimization
problems further aggravates ﬁnding the global minimizer with
conventional gradient-based methods. Therefore a probabilistic
metaheuristic called simulated annealing (SA) (35) is used to
ﬁnd a (local) minimum. This iterative and stochastic optimiza-
tion method is inspired by the annealing of metals, where the
metal is heated to a certain temperature and then cooled down
according to a schedule. The energy state of the resulting crys-
tals strongly depends on the initial temperature and the cooling
schedule. These ideas can be transferred to optimization prob-
Figure 4. This ﬁgure illustrates possible moves taken in the optimization of the switches connecting the ampliﬁers to the
coil element network. The conﬁguration Y1 is equivalent to the conﬁguration X2 of Figure 3. The difference between Y2
and Y1 is that in conﬁguration C1, Amp1 is connected the other way around. Note that the terminals of E1 and E2 are
still connected in the same way as in Y1. In addition, in conﬁguration C2, the ampliﬁers are swapped such that Amp2
now powers the ﬁrst cluster and Amp1 the second cluster. None of the possible moves this optimization can perform can
inﬂuence the result of the previous optimization illustrated in Figure 3. The ﬁnal row shows all connections for the differ-
ent conﬁgurations. For this toy example, the maximum number of switches is 12. The ordering Y1 has 3 shared connec-
tions (from terminal 1 of Amp1 to p21, from terminal 1 of Amp2 to p31, and from terminal 2 of Amp2 to p42). Owing to 3
shared connections, the ordering number of switches reduces to 9. In Y2, there are again 3 shared connections (from
terminal 1 of Amp1 to p31, from terminal 1 of Amp2 to p31, and from terminal 2 of Amp2 to p11 of E1 p42). The connection
from Amp2 to p42 is special, as this is wired for every conﬁguration, meaning that there is no switch necessary, and in-
stead, it can be hard-wired. In total, the number of switches for Y2 reduces to 7.
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lems, where instead of metals, parameter vectors are “heated up”
to a temperature T0, and then cooled down by reducing the
temperature over the course of the iterations. The parameter
vectors are randomly modiﬁed in each iteration by a degree
proportional to the temperature. These modiﬁcations (some-
times also called moves) are performed by a problem-speciﬁc
annealing function. After every iteration, the temperature is
reduced according to a cooling schedule. The cooling schedule
used in this work is T0/i, where i is the current iteration number,
which has worked well during our simulation experiments. This
means that in early iterations with high temperature, the param-
eter space will be explored randomly by performing big “jumps,”
while later iterations with lower temperature will focus on im-
provements in close proximity to the current position of the
parameter vector in the parameter space. The quality of every
parameter vector is calculated by the so-called cost function.
Better solutions are always accepted; however, worse solutions
may also be accepted with a probability given by P  1/(1 
exp(
/T)), where 
 is the absolute difference of the previous and
current cost function value. This is beneﬁcial for overcoming
local minima. The acceptance probability increases with tem-
perature and small 
. When the current best cost function value
has not improved for NSAmax iterations, we consider it con-
verged and stop the optimization. Note that this method is not
guaranteed to ﬁnd the global optimum.
Annealing Function
The annealing function deﬁnes how a parameter vector is mod-
iﬁed in each iteration of the SA algorithm. It depends on the
temperature Ti of iteration i. If the temperature is high, more
modiﬁcations will be performed. In the case of minimizing the
number of switches between coil elements (Algorithm 1), the
annealing function randomly performs 1 of 2 operations with
the same probability. It either picks 2 random elements within a
randomly chosen cluster of a randomly chosen conﬁguration
and swaps them to change the ordering or reverses the polarity
of a randomly chosen coil element (which can be accounted for
in the actual implementation of the circuit by adapting the state
of the switches of the corresponding bridge switch). This step is
repeated several times depending on Ti.
When minimizing the number of switches from the ampli-
ﬁers to the coil element network, the annealing function
(Algorithm 2) randomly changes how ampliﬁers are assigned to
clusters within randomly chosen conﬁgurations. In other words,
within a conﬁguration, the positions of some of the ampliﬁers in
the network are randomly permuted as this may affect the
number of switches. The concept is illustrated in Figure 4 using
a toy example, where swapping ampliﬁers Amp1 and Amp2 in
conﬁguration C2 and changing the direction how Amp1 in C1 is
connected to the ﬁrst cluster reduced the number of necessary
switches by 2. The number of times this procedure is repeated
depends again on the temperature.
Optimization Settings
To assess the performance of the optimization algorithm, ran-
domly generated conﬁgurations were used. The conﬁgurations
were generated for NF {3, 9, 15, 21, 27} (number of ﬁelds) and
NA  {6, 12, 24, 36, 42} (number of ampliﬁers/clusters). The
range of the number of ﬁelds is not based on speciﬁc applica-
tions, but it was chosen to cover a large range with equidistant
spacing. All conﬁgurations are based on a matrix gradient coil
with NC  84 coil elements. For each setting, ND  100 random
conﬁgurations were created. Each optimization is run for
NR  4 times to account for the statistical nature of the solver.
For creating the random conﬁgurations, the minimum and max-
imum numbers of coil elements per ampliﬁer are set to NCmin  2
and NCmax  15, respectively. This large amount of randomly
created conﬁgurations covers a large range of possible cases and
is used here as a means to assess the performance of the algo-
rithm. Note that these randomly created conﬁgurations are
likely to not produce useful magnetic ﬁelds. In addition, the
algorithm has been tested on a subset of the (realistic) conﬁgu-
rations obtained in Kroboth et al.’s study (26) for an
NC  84 channel matrix gradient coil. These conﬁgurations
where designed for NA  {6, 12, 24, 42} (number of ampliﬁers/
clusters) to create spherical harmonics up to full third order (15
ﬁelds). Here we optimize a switching circuit for the ﬁrst 3, 9, and
15 conﬁgurations. The number of conﬁgurations were chosen
Algorithm 2. Annealing Function 2
1: for or j  <Ti=  1 do
2: Cr ¢ random conﬁguration
3: v1 ¢ random ampliﬁer index 1
4: v2 ¢ random ampliﬁer index 2
5: if random(0, 1)  0.5 then
6: Yi ¢ swap_ampliﬁers(Yi, Cr, v1, v2)
7: else
8: Yi ¢ ﬂip_ampliﬁer_orientation(Yi, Cr, v1)
9: end if
10: j ¢ j  1
11: end for
12: Return Yi
Algorithm 1. Annealing Function 1
1: for j  <Ti=  random_integer(1, 5) do
2: Cr ¢ random conﬁguration
3: Kr ¢ random cluster in Cr
4: e1 ¢ random element index 1 in Kr
5: e2 ¢ random element index 2 in Kr
6: if random(0,1)  0.5 then
7: Xi ¢ swap_elements(Xi, e1, e2)
8: else
9: Xi ¢ ﬂip_element_orientation(Xi, e1)
10: end if
11: j ¢ j  1
12: end for
13: Return Xi
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such that the results are comparable to the results obtained with
the random conﬁgurations (they do not correspond to the num-
ber of basis functions contained in certain orders of spherical
harmonics). For all runs, the initial temperature was set to T0 104,
and the maximum number of iterations where the best cost func-
tion value has not changed was set to NSAmax  2·104 (stopping
criterion). These parameters were experimentally found to ob-
tain good results. The software has been implemented in the
Matlab (The MathWorks, Natick, MA) programming language
using Matlab’s Global Optimization Toolbox. Each optimization
was executed on a single CPU core without parallelization.
RESULTS
Combinations of different hardware setups with a large range of
numbers of conﬁgurations have been investigated. Figure 5
shows the comparison between the unoptimized and optimized
cases for randomly generated conﬁgurations. Each bar includes
100 different optimization instances where each is run 4 times,
leading to a total of 400 data points per bar. As it would not be
fair to compare the optimized switching circuit to the full
switching circuit, the optimized circuits are compared with the
unoptimized switching circuit. The unoptimized switching cir-
cuit is based on the ordering given by the method that produces
the conﬁgurations. In case of the random conﬁgurations, the
initial, unoptimized ordering of coil elements within clusters
and the assignment of ampliﬁers to the coil element network is
random. For the realistic conﬁgurations, the optimization algo-
rithm of Kroboth et al.’s study (26) does not consider the order-
ing of the coil elements within clusters and the assignment of
ampliﬁers to the network; therefore, the ordering can also be
considered random. Note that therefore the unoptimized case is
rather an average case than a worst-case scenario.
Optimization 1—Switches Between Coil Elements
As expected, the number of required switches increases with the
number of conﬁgurations that are to be switched. This is because
the number of different pathways through the coil element
network increases with the number of conﬁgurations. The
switching circuit needs to be able to realize all these pathways,
which in general, comes with the need to increase the number of
necessary switches. For the investigated range of conﬁgura-
tions, the number of switches after optimization ranges from

200 switches (3 conﬁgurations) to 
1000 switches (27 con-
ﬁgurations). The inﬂuence of the number of ampliﬁers (which is
equal to the number of clusters, as each ampliﬁer is connected to
a cluster) is rather small, at least for the optimized case. In the
unoptimized case, fewer ampliﬁers/clusters lead to an increase
in the number of switches. The optimization however is capable
of reducing this substantially, see, for instance, the case of 15
conﬁgurations and 6 ampliﬁers. In comparison, for a large
number of ampliﬁers (ie, 15 conﬁgurations and 42 ampliﬁers),
the optimization only leads to a small reduction. This suggests
that the number of conﬁgurations to be switched is the domi-
nating factor in terms of number of switches between coil
elements, while the actual composition of the individual con-
ﬁgurations plays a minor role.
Optimization 2—Switches Between Amplifiers and Coil
Elements
The results of this part also depend on the number of conﬁgu-
rations; however, this time there is also a pronounced depen-
Figure 5. Comparison of the
unoptimized (hatched bars) with
the optimized case. The mean
values of the number of switches
between coil elements (before and
after optimization 1) and the num-
ber of switches from the ampliﬁers
to the coil elements (before and
after optimization 2) are stacked
to show the total number of
switches. Different setups (3 to 27
conﬁgurations and the number of
ampliﬁers ranging from 6 to 42)
were evaluated. Per bar, 100 ran-
dom conﬁgurations were created
where each conﬁguration uses all
84 coil elements. Each optimiza-
tion instance was run 4 times,
therefore the total number of data
sets per bar is 400. The variation
over all runs is indicated with er-
ror bars.
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dency on the number of ampliﬁers: more ampliﬁers require
more switches. However, the reduction of switches from unop-
timized to optimized suggests that the more ampliﬁers, the
higher is the potential for minimization, as there are more
degrees of freedom to exploit. This means that this optimization
is more effective for a large number of ampliﬁers, but effec-
tively, a lower number of ampliﬁers leads to fewer necessary
switches. Over all investigated data sets, the number of switches
between ampliﬁer and coil element terminals after optimization
ranges from 
30 to slightly over 
1130.
Combined Results of Optimizations 1 and 2
For a given number of conﬁgurations, it is favorable to have a
low number of ampliﬁers. However, from the results in Kroboth
et al.’s study (26), we know that for a low number of ampliﬁers,
it is in general more difﬁcult to obtain a conﬁguration which is
capable of accurately creating a desired target ﬁeld. This is
because lowering the number of ampliﬁers essentially limits the
number of different current values ﬂowing through the coil and
hence restricts the coil’s capabilities to accurately reproduce
target ﬁelds. Therefore, the number of ampliﬁers is usually
dictated by the desired ﬁeld accuracy in the optimization of the
conﬁgurations, as shown in Kroboth et al.’s study (26). The
optimization algorithms themselves perform best for a low num-
ber of ampliﬁers, leading to a reduction (compared to the un-
optimized case) ranging from 
8% to 
44%. The average re-
duction across all investigated data sets is 
31%.
Realistic Configurations
The algorithm has furthermore been tested on a subset of the
conﬁgurations obtained in Kroboth et al.’s study (26). These
conﬁgurations were designed such they are able to create spher-
ical harmonics up to full third order for 6, 12, 24, 42 ampliﬁers.
The median least squares error of all 15 conﬁgurations com-
pared with the desired target ﬁelds was 
10% for 6 ampliﬁers,

5% for 12 ampliﬁers, and 
2.5% for 24 ampliﬁers (includ-
ing all 84 channels driven individually). Figure 6 shows the
results for switching circuits optimized to switch between the
ﬁrst 3, 9, and 15 conﬁgurations. These results are in line with
the results shown in Figure 5. This afﬁrms the assumption that in
practice, the number of switches depends stronger on the hard-
ware setup such as the number of ampliﬁers and the number of
conﬁgurations than on the actual composition of the conﬁgu-
ration.
DISCUSSION
Many parameters require consideration when designing a ma-
trix gradient coil. Mainly, the coil should be suitable for the task
at hand, but also the technical effort and costs associated with it
cannot be neglected. The parameters that inﬂuence the coil’s
capabilities and technical effort are (among others) the number
of coil elements, the number of ampliﬁers, and the complexity of
the switching circuit. This work in combination with Kroboth et
al.’s study (26) aims to shed light on the relationship between
those parameters in terms of both technical effort and ability to
create ﬁelds. In Kroboth et al.’s study (26), we showed (in case of
the matrix gradient coil) that even with a reduced number of
ampliﬁers, a large range of ﬁeld shapes can be created accu-
rately. Here we extend the previous work by showing how the
number of switches needed for a switching circuit can be re-
duced. By changing the order of coil elements within clusters
and by varying which ampliﬁer supplies which cluster of a
conﬁguration with current, we were able to reduce the number
of switches by up to
44% without affecting the conﬁgurations’
ability to create a target ﬁeld at a desired accuracy. Many
random conﬁgurations were used to assess the algorithms on a
wide range of different situations. To address the statistical
nature of the optimization algorithms, each instance was opti-
mized 4 times. In addition, a subset of the conﬁgurations opti-
mized in Kroboth et al.’s study (26) was used to show the
performance of the algorithms on a realistic setup. The problem
of minimizing the switches was split into 2 sequential optimi-
zation problems. At ﬁrst, given a set of conﬁgurations, the
number of switches connecting the terminals of all the coil
elements with each other is minimized. Based on the results, the
number of switches that connect the ampliﬁers to the clusters is
minimized. Both problems pose challenging combinatorial op-
timization problems, which were solved with the use of SA. In
the early stages of development, the problem was also solved
with a genetic algorithm (GA); however, initial tests showed that
performance was similar compared with SA. Given that GA has
substantially more parameters to tune, SA was chosen. With
proper tuning, we expect that GA can outperform SA in terms of
speed; however, ﬁnding the perfect tuning is difﬁcult given that
it is likely problem-dependent. One major advantage of GA is its
potential ability to extensively explore the parameter space
owing to cross-over. Similar effects can be achieved by high
Figure 6. Comparison of the unoptimized case
(hatched bars) with the optimized case for the ﬁrst
3, 9, and 15 conﬁgurations published in Kroboth
et al.’s study (26). Each optimization instance was
run 100 times to account for the statistical nature
of the solver. The variation of these runs is indi-
cated with error bars. The general trends match
Figure 5.
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initial temperatures and/or multiple runs of SA in parallel.
Unfortunately, the solution space of the second optimization
may, in principle, be constrained by the solution of the ﬁrst in an
unfavorable way. To avoid this, both problems can be solved in
a single optimization problem. However, this problem is much
more complex, and the results of a pilot study were consistently
worse than that of the proposed methods (data not shown).
In addition to reducing the number of switches, the results
of this work also expose the relationships between the number
of conﬁgurations and the number of ampliﬁers. Figure 5 gives
insight into how the complexity of the switching circuit scales
with different hardware setups. Running both optimizations
requires
30 minutes to
8 hours depending on the parameters.
The biggest inﬂuence on the runtime is the number of conﬁgu-
rations. Because switching circuits are not changed or modiﬁed
often, these long run-times are acceptable. The proposed method
operates on conﬁgurations only and is therefore independent of
the actual matrix gradient coil design, as conﬁgurations can be
computed for any design.
The resulting optimized numbers of switches in the range of

200 to 
1200 may appear to be high. Indeed the gradient
array method (24) allows to create one localized Z gradient,
which is movable along the Z direction without the need for
switches (but using 3 gradient ampliﬁers). It is currently unclear
how many gradient channels and ampliﬁers would be required
to extend this approach of moveable FOVs to 3 spatial dimen-
sions. Contrary to that, the dynamically controlled adaptive
current network approach (33), which was recently introduced
for shimming, relies on a single current ampliﬁer, but it requires
a substantial number of switches. As noted by the authors, for a
body-sized coil with 2-cm wire spacing, 6000 switches would be
required. To achieve surface current densities comparable to that
of the present matrix coil (2) the number of switches would
increase to 25 000. Compared with that, the matrix coil setup
with a switching circuit, capable of generating a full third-order
spherical harmonic set, driven by only 12 ampliﬁes and con-
trolled by 
900 switches, appears to be favorable for imaging
applications. It is further to be noted that none of the clusters in
any of the conﬁgurations contained15 elements connected in
series, which is advantageous with regard to the voltage drop
and the power dissipation in the coil.
One potential future step could be combining the optimiza-
tion of conﬁgurations (26) with the optimization of the switch-
ing circuit presented in this work. However, this would be a
substantially harder optimization problem, which additionally
has 2 objectives (ﬁeld accuracy and number of switches). Alter-
natively the conﬁguration optimization and switching circuit
optimization could be merged partially. For instance by favoring
conﬁgurations that offer good starting conditions for the
switching circuit optimization. These conditions need to be
deﬁned, and their effectiveness and their feasibility have to be
assessed in future work. In this current work, it was assumed that
each coil element is equipped with a bridge (Figure 2B); how-
ever, not every element may require such a bridge. In future
work, the switches of the bridges could be included into the
optimization to further reduce the technical effort. Furthermore
it was assumed that the ampliﬁers are bipolar which is common
for gradient channels. With adaptions, the optimization could
also be performed with unipolar ampliﬁers. This also remains
part of further research.
The setup shown in Figure 1 does not allow for the super-
position of ﬁelds created by different conﬁgurations; however,
each conﬁguration can potentially create many different ﬁeld
shapes by changing the currents through the individual clusters.
Therefore there are many more degrees of freedom for encoding
than this diagram may suggest. Theoretically, the switching
circuit offers more paths through the network of coil elements
than it is optimized for which can be exploited for the creation
of ﬁelds. Unfortunately, ﬁnding all possible or reasonable paths
is also a computationally complex problem and the obtained
additional functionality most likely does not scale well with the
invested effort.
Also the dynamically controlled adaptive current networks
B0-shimming method (33) can beneﬁt from the methodology
presented here. In the original approach, desired current patterns
are approximated by a dense network of small wire paths con-
nected with MOSFETs, leading to very high ﬂexibility for the
creation of a wide range of current densities, with many of them
leading to similar ﬁeld shapes. The method presented here may
be used to sparsify the dense switch network by eliminating the
switches that are irrelevant for effective ﬁeld creation and hard-
wiring the connections that are persistent across the set of the
relevant target ﬁelds. The methodology and results presented in
this work can further serve as a valuable tool for the search of
such tradeoffs by combining it with the various approaches from
the literature (2, 4, 24, 33).
CONCLUSION
We presented a method which reduces the effort associated with
a switching circuit for matrix gradient coils by minimizing the
number of switches for a given set of conﬁgurations without
affecting the conﬁgurations’ ability to accurately create a de-
sired target ﬁeld. The results give insights in the relationship
between the number of switches and different parameters, which
are important for the design of matrix gradient coils.
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Accuracy of Arterial Input Function Measured
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(COCMRI), cardiac output from DCE-MRI (CODCE), computed tomography (CT), repetition time
(TR), echo time (TE), ﬂip angle (FA), ﬁeld of view (FOV), gadolinium (Gd), region of interest (ROI),
standard deviation (SD)
Accurately measuring arterial input function (AIF) is essential for quantitative analysis of dynamic contrast-
enhanced (DCE) magnetic resonance imaging (MRI). We used the indicator dilution principle to evaluate the
accuracy of AIF measured directly from an artery following a low-dose contrast media ultrafast DCE-MRI. In
total, 15 patients with biopsy-conﬁrmed localized prostate cancers were recruited. Cardiac MRI (CMRI) and
ultrafast DCE-MRI were acquired on a Philips 3 T Ingenia scanner. The AIF was measured at iliac arties fol-
lowing injection of a low-dose (0.015 mmol/kg) gadolinium (Gd) contrast media. The cardiac output (CO)
from CMRI (COCMRI) was calculated from the difference in ventricular volume at diastole and systole mea-
sured on the short axis of heart. The CO from DCE-MRI (CODCE) was also calculated from the AIF and dose
of the contrast media used. A correlation test and Bland–Altman plot were used to compare COCMRI and
CODCE. The average (standard deviation [SD]) area under the curve measured directly from local AIF was
0.219  0.07 mM·min. The average (SD) COCMRI and CODCE were 6.52  1.47 L/min and 6.88 
1.64 L/min, respectively. There was a strong positive correlation (r  0.82, P  .01) and good agreement
between COCMRI and CODCE. The CODCE is consistent with the reference standard COCMRI. This indicates
that the AIF can be measured accurately from an artery with ultrafast DCE-MRI following injection of a low-
dose contrast media.
INTRODUCTION
Dynamic contrast-enhanced (DCE) magnetic resonance imaging
(MRI) has been widely used for cancer diagnosis, as well as to
quantitatively and noninvasively estimate a lesion’s physiolog-
ical characteristics (1-5). Quantitative DCE-MRI analysis is usu-
ally performed by using a pharmacokinetic model to obtain
transfer rate constants, such as Ktrans (forward volume transfer
constant) and kep (reverse reﬂux rate constant between extra-
cellular space and plasma) to characterize cancers (6, 7). How-
ever, variations of arterial input function (AIF) have a strong
impact on calculations of physiological parameters (8-11). To
extract reliable physiological parameters, an accurate AIF must
be measured for each patient to account for variations in cardiac
output (CO), systemic vascular function, and injection protocol
(8). Unfortunately, there is potential for signiﬁcant error in AIF
measurements owing to partial volume effects, respiratory mo-
tions, inﬂow artifacts, dose-dependent T2*, and water exchange
effects (12-14). To avoid problems with accurate measurement
of patient-speciﬁc AIFs, a population AIF is often used in quan-
titative DCE-MRI data analysis (15-17). However, this does not
account for the large interpatient and interscan variability,
and this makes it difﬁcult to compare physiological parame-
ters between patients or measure changes in each patient over
time (18, 19).
Several investigators have developed methods for quanti-
tatively measuring patient-speciﬁc AIFs with MRI (10, 20, 21).
However, the accuracy of the measured AIF was not veriﬁed in
most studies. Previous studies reported that using CO combined
with capillary input function improved the estimation of phar-
macokinetic parameters for liver (22). By applying the indicator
dilution principle (23) to constrain the area under the ﬁrst pass
of the AIF, Zhang et al. (24) reported a 3-fold higher precision in
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calculating tumor perfusion parameters (Ktrans and ve). Di Gio-
vanni et al. (25) reported a method for estimating perfusion
parameters in patients with breast cancer using a T2*-weighted
DCE data set optimized with CO. All of these studies applied the
indicator dilution principle to optimize (scale) AIF based on each
patient’s CO. The need for this adjustment indicates that there
were signiﬁcant errors in the directly measured AIFs. Several
studies also compared the AIFs measured from DCE-MRI and
DCE computed tomography (CT) scans (26-28), where the AIF
obtained from CT was treated as gold standard. However, the
accuracy of this comparison was limited because of radiation
dose constraints on temporal sampling with dynamic CT. In
addition, this approach to validation entails radiation and ad-
ditional contrast media.
In the present study, the indicator dilution principle was
used to verify the accuracy of the AIF directly measured at the
iliac arties following injection of a very low-dose contrast me-
dia. The key difference from previous studies is to verify, but not
to optimize (scale), the measured AIF. The CO of each patient was
directly calculated from short-axis cardiac MRI (CMRI) data. A
high temporal resolution (ultrafast) prostate DCE-MRI scan was
acquired with a low-dose contrast media, that is, 15% of the
conventional amount, to avoid errors due to T2* changes and
water exchange.
METHODOLOGY
Patient
This study was approved by the Institutional Review Board.
Patients were enrolled from January 01, 2017, to March 01,
2018. Informed consent was obtained from all patients before
conducting any study procedures. All patients enrolled in
this study had prostate cancer proven by TRUS (transrectal
ultrasound)-guided biopsy and were scheduled for radical prosta-
tectomy at our hospital. Patients with previous treatments (radia-
tion or chemotherapy) for prostate cancer, any type of bioimplant,
moderate or high anxiety and/or claustrophobia, and contraindi-
cations for MRI or CT including impaired renal function (GFR 60
mL/min) were excluded from the study.
Fifteen patients (average age, 59 years; range, 47–73 years;
average weight, 96.7 kg; range, 79–132 kg) received both car-
diac MRI (CMRI) and a subsequent prostate DCE-MRI scans on
the same day. The cohort comprised Gleason grade 6–9 lesions
including: Gleason score (GS) 3  3 (n  2), GS 3  4 (n  11),
GS 4  3 (n  6), and GS 4  5 (n  1).
CMRI and Prostate DCE-MRI Scan Protocols
Both CMRI and low-dose (0.015 mmol/kg of gadobenate dime-
glumine) ultrafast DCE-MRI were acquired on the same Philips 3
T Ingenia scanner (Philips Healthcare, Best, Netherlands). A
gradient echo sequence (B-TFE) was used for imaging the car-
diac short axis (repetition time [TR]  3.2 milliseconds, echo
time [TE] 1.6 milliseconds, ﬂip angle [FA] 45°, ﬁeld of view
[FOV]  30  30 cm2, slices  14, phases  30–40, gap  0,
in-plane resolution  1.0  1.0  8 mm3, maximum dynamic
time  800–1025 milliseconds).
Prostate MRI scans were performed approximately 30 minutes
after the CMRI scan. First, clinically required prostate MRI scans,
including high-resolution axial T2-weighted MRI and diffusion-
weighted imaging, were acquired. Then variable FA 3D-FFE-T1
scans (TE/TR  2.3/12 milliseconds; FA  3°, 5°, 10°, 15°, 20°,
30°; FOV  25  39 cm2; in-plane resolution  1.25  1.75
mm2; thickness  3.5 mm) were acquired for the calculation of
native T1. Next, 150 axial ultrafast DCE-MRI using an mDixon
sequence (27, 29, 30) (TE1/TE2/TR  1.5/2.8/4.2 milliseconds,
FA 10°, FOV 18 37 8 cm3, in-plane resolution 1.5
2.8 3.5 mm3, temporal resolution 1.5 s) were acquired over
225 seconds. A small dose (15% of the conventional dose, 0.015
mmol/kg) of Gd-based contrast media (gadobenate dimeglu-
mine) was injected into the patients’ left arm median cubital
vein with a power injector at an injection duration of 	1.5
seconds, and followed by a 20-mL saline ﬂush. The ﬁrst 10 sets
of ultrafast DCE-MRI images were precontrast scans used as
baseline images. An approximate standard dose of contrast
media was injected 	5 minutes after the low-dose contrast
media DCE-MRI. Data from the standard dose were not used in
the work reported here.
CO Measurements from CMRI
Electrodes were attached on the patient’s chest during the CMRI
scan to monitor the patient’s electrocardiogram. The CO from
CMRI (COCMRI) was calculated on the basis of the difference
between ventricular volume at diastole and at systole measured
on the short axis of the heart using the following formula
(31-33):
COCMRI HR (VED VES) (1)
where VED (L) is the volume at the end of diastole, VES (L) is the
volume at the end of systole, and HR (beats/min, bpm) is the
patient’s heart rate recorded from electrocardiogram.
Contrast Media Concentration Measurements from
DCE-MRI
For all DCE-MRI slices, the contrast media concentration as a
function of time was calculated by using a previously published
method (34) based on MRI TR, FA, native T1, and baseline signal.
The native T1 was calculated by using the acquired precontrast
dual-TR and variable ﬂip angle images as previously described
(35-37). The relaxivity of the contrast media of 5.5 L/mmol/s
(38) was used to calculate the Gd concentration in millimolar
units. AIFs were extracted from ultrafast DCE-MRI by manually
tracing the region of interest (ROI) over the left and right iliac
arteries. The shapes of the ROIs changed on different slices
owing to blood vessel visibility variations on DCE-MRI. The
average (standard deviation [SD]) size of the ROI was 18  6
pixels. The vessel walls could be easily excluded from the con-
tour because they had different contrasts compared with the
vessel lumen. The average contrast media concentration from
the left and right iliac arteries was calculated and used as the AIF
for the patient.
The accuracy of the measured AIF was veriﬁed by using the
indicator dilution theory, which states that the area under a
curve of the blood plasma contrast media concentration during
the ﬁrst-pass perfusion is constant in every vessel (25). The CO
measured from CMRI versus DCE-MRI should be the same if the
AIF is accurately measured.
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Figure 1. Cardiac output (CO)
calculation from cardiac magnetic
resonance imaging (CMRI) where
(A) is a a section of short-axis
CMRI during a full CO. Row 2,
column 2, image shows the mini-
mum cross-section area during the
end of the systolic period; row 4,
column 8, image shows the maxi-
mum cross-section area during the
end of the diastolic period; (B) is
the plot of ventricular volume mea-
sured from short-axis CMRI.
Figure 2. The ultrafast dynamic
contrast-enhanced (DCE) image
following a low dose of contrast
media from the same patient (at
the 40th dynamic scan) (A), the
subtracted dynamic image from
baseline shows early enhance-
ment in prostatic carcinoma (red
arrow) (B), and the AIF generated
from iliac artery (red circle) from
the ultrafast DCE-MRI data (C).
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CO Measurements from Ultrafast DCE-MRI
The CO from ultrafast DCE-MRI (CODCE) was calculated from the
AIF and the dose of contrast media (24):
CODCE Q ⁄  Cp(t)dt (2)
where Q (mmol) is the amount of the contrast media injected,
and CP(t) (mM) is the contrast media concentration in the blood
plasma. The area under the “ﬁrst pass” of contrast media circu-
lation was used for integration, that is, from baseline immedi-
ately before bolus arrival to the end of the ﬁrst pass of the
contrast media bolus.
Data Analysis
Paired Student t-test was used to compare the COCMRI and
ultrafast CODCE. Pearson correlation test was performed to ex-
amine whether there is a linear relationship between COCMRI and
CODCE. The agreements between COCMRI and CODCE values were
evaluated using Bland–Altman analysis. P .05 was considered
signiﬁcant.
RESULTS
CMRI was acquired ﬁrst for calculating CO as a reference stan-
dard. Figure 1A shows typical images of the short axis of the
heart during a cardiac cycle. The image in row 2, column 2, has
the minimum cross-sectional area during the end of the systolic
period; the image in row 4, column 8, has the maximum cross-
sectional area during the end of the diastolic period. The corre-
sponding plot of ventricular volumes measured from short axis
of the heart as a function of time is shown in Figure 1B. The VED
and VES used in equation (1) for calculating COCMRI were the
maximum and minimum values, respectively, in the plot.
After CMRI, prostate DCE-MRI was acquired, and the AIF was
measured directly from the iliac arteries. Figure 2A shows the
ultrafast DCE image (at the 40th dynamic scan) from the same
patient as shown in Figure 1. The subtracted dynamic image (Figure
2B) from the baseline (averaged from all baseline frames) shows
early enhancement in prostatic carcinoma (red arrow), and the AIF
traced from the iliac artery (red circle) is shown in Figure 2C. The
ﬁrst and second pass peaks of the contrast bolus can be clearly seen
in theAIF despite limited signal-to-noise ratio owing to injection of
the low-dose contrast media.
This data analysis procedure was applied to data from all 15
patients. Table 1 lists the patients’ heart rate, the area under the
curve measured directly from local AIF, and the calculated
CODCE and COCMRI as the reference standard. The average (SD)
area under the curve measured directly from local AIF obtained
from ultrafast DCE-MRI is 0.219  0.07 mM·min. The average
(SD) COs calculated from CMRI and DCE-MRI are 6.52  1.47
L/min and 6.88  1.64 L/min, respectively. Both COCMRI and
CODCE vary by over a factor of 2 in this group of patients. Figure
3A shows the scatter plot of the COCMRI vs CODCE. There are
strong positive correlations (r  0.82, P  .01) between the
COCMRI and CODCE. The corresponding Bland–Altman plot shows
good agreement between the two CO measurements (Figure 3B)
with bias of 0.37 (L/min) and limits of agreement between1.14
to 1.87 (L/min).
DISCUSSION
The indicator dilution principle was used to verify the accuracy
of AIF measured at iliac arties from ultrafast DCE-MRI scan after
injection of the low-dose contrast media. The subject’s CO was
directly measured from CMRI before the prostate DCE-MRI scan.
We showed that the CO measured from ultrafast DCE-MRI is
consistent with the “gold standard” CO measured from the short-
axis CMRI. Our results show that AIF can be accurately mea-
sured directly from an artery with ultrafast DCE-MRI following
injection of a low-dose contrast media. Accurate measurement
of AIF for individual patients is critical for pharmacokinetic
analysis.
The present results also suggest some clinical and diagnos-
tic advantages for use of a low-dose contrast media DCE-MRI
(39). The association between Gd-based contrast media admin-
istration and nephrogenic systemic ﬁbrosis has been a concern
for patients with renal failure. In a retrospective study, acute
renal failure was reported after high-dose (0.2 mmol/kg) Gd
injection for patients with an eGFR lower than 30 mL/min (40).
It has also been reported that high-dose Gd injection contributed
to an increased risk of nephrogenic systemic ﬁbrosis (41). There
are increasing concerns regarding intracellular accumulation of
Gd-based contrast media (42). Therefore, a low-dose contrast
media is preferred to minimize the risk (39). In addition, a
standard dose of contrast media may lead to erroneous estima-
tion of AIF owing to the high concentration of the contrast,
water exchange effects, and T2* effects (12-14). The AIF mea-
sured from a low-dose contrast media may reduce such errors, as
demonstrated by the present study results. In addition, this was
previously shown by comparing results from ultrafast DCE-MRI
with those from DCE-CT with 120-mL Iohexol in 20 patients
with prostate cancer (27). Previous work from this group showed
Table 1. Patients’ Heart Rate, Area Under
the Curve Measured Directly from Local AIF,
and CODCE and COCMRI
No.
Heart Rate
(beats/min)
AIF (AUC)
(mM·min)
CODCE
(L/min)
COCMRI
(L/min)
1 66 0.228 5.92 5.90
2 68 0.252 5.63 5.90
3 73 0.203 6.37 5.70
4 53 0.189 6.88 7.70
5 47 0.440 2.73 3.99
6 82 0.175 7.20 6.54
7 60 0.174 7.47 5.80
8 63 0.170 8.24 7.74
9 67 0.225 6.67 6.01
10 60 0.229 6.81 5.50
11 65 0.163 8.56 7.90
12 61 0.149 8.66 7.92
13 65 0.266 5.64 5.10
14 58 0.169 9.67 9.96
15 51 0.247 6.80 6.10
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that low-dose Gd contrast distinguishes prostate cancer from
benign prostate tissue more effectively than a standard dose on
the basis of the signal enhancement rate; this diagnostic accu-
racy is similar on qualitative assessments (39).
CO is an important physiological parameter that directly
relates to the metabolism of the entire organism (43). Results
from the current group of patients show that there is a wide
variation in CO (over a factor of 2) and this will result in large
errors in pharmacokinetic parameters if it is not properly ac-
counted for. A separate magnetic resonance sequence is often
used to obtain CO. Our method with a low-dose contrast media
and ultrafast DCE of the abdomen can provide accurate AIF and
measure CO simultaneously, without performing additional
scans, and with minimal exposure to contrast media.
Our measurements of CO and AIF are not perfect. For ex-
ample, the native T1 measurement has a strong effect on Gd
concentration calculation and AIF curve shape. This is because
other parameters used in the calculation of contrast media
concentration are dependent on MRI acquisition parameters. In
addition, the native T1 must be determined from additional MRI
scans that can contribute error. The CMRI slice thickness (8 mm)
can be reduced to more accurately measure the diastolic and
systolic volume for more accurate CO calculation. The measure-
ment errors in VED and VES would only linearly affect COCMRI
calculations, which were naturally smaller than errors in CODCE
calculations owing to the many calculations involved.
In conclusion, accurately measuring of the AIF is essential for
quantitative DCE-MRI. Here we compared the CO measured from
CMRI as reference standard with the CO determined from measure-
ment of the AIF with ultrafast DCE-MRI. The results validated the
accuracy of the AIF measured at iliac arties following injection of a
low-dose (0.015 mmol/kg) Gd contrast media. The low dose chosen
for this study may not be optimal for measuring AIF and/or for the
diagnosis of cancers. More studies are needed to determine the
optimal low dose for both accurately measuring the AIF and esti-
mating physiological parameters.
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Percutaneous minimally invasive interventions are difﬁcult to perform in closed-bore high-ﬁeld magnetic
resonance systems owing to the limited space between magnet and patient. To enable magnetic resonance–
guided needle interventions, we combine a small, patient-mounted assistance system with a real-time instru-
ment tracking sequence based on a phase-only cross-correlation algorithm for marker detection. The
assistance system uses 2 movable plates to align an external passive marker with the anatomical target struc-
ture. The targeting accuracy is measured in phantom experiments, yielding a precision of 1.7  1.0 mm for
target depths up to 38  13 mm. In in vivo experiments, the possibility to track and target static and moving
structures is demonstrated.
INTRODUCTION
Magnetic resonance imaging (MRI) has unique advantages to
guide and monitor interventional procedures over other imag-
ing methods such as computed tomography or ultrasound (US).
It offers an unparalleled soft tissue contrast, it can acquire
images in arbitrary scan planes along the device trajectories, it
provides morphological and functional imaging, and it exposes
neither the patient nor the interventionalist to ionizing radia-
tion. MRI can be used at various stages of the intervention—
during target localization, device positioning, monitoring of
therapeutic progress, and assessment of therapeutic outcome
(1-3). Besides intravascular (4) and thermal treatments [e.g.,
with high-intensity focused ultrasound (5-7)], minimally inva-
sive percutaneous interventions such as needle biopsies tremen-
dously beneﬁt from image guidance (8, 9).
Percutaneous interventional procedures have traditionally
been performed in open-bore low-ﬁeld magnetic resonance
(MR) systems to ensure good patient access (10). However, a
good contrast-to-noise ratio is required to differentiate the tar-
get region from the surrounding tissue, a high signal-to-noise
ratio is needed to unambiguously visualize the instruments in
the patient’s body, and an adequate spatial resolution needs to
be ensured to detect, e.g., small deviations from the planned
needle pathway. Currently, these requirements are best fulﬁlled
in high-ﬁeld, high gradient power MRI systems at 1.5 T or 3 T,
which are typically constructed as solenoid superconducting MR
magnets. However, spatial constraints because of the closed-bore
design (typical bore diameter of70 cm, cover-to-cover length in
the range of 125–160 cm) limit the physicians’ access to the patient
and make device handling challenging. Assistance systems can
help overcome these problems and facilitate percutaneous inter-
ventions (1-3, 11). Such systems have been shown to improve
needle placement (12, 13), help to achieve needle trajectories with
increased precision, and help to shorten procedure durations
(14-17). Any assistance system operating in the MRI environment
must not only conform to all conventional safety standards for
MRI accessories but also preserve the MR image quality, and its
operation has to remain unaffected by the MR system’s radio-
frequency and magnetic ﬁelds. This makes the construction of
assistance systems for the MR environment a challenging task.
In recent years, assistance systems have been presented for
numerous applications with various degrees of remote control
and haptic feedback. The fully MR-compatible pneumatic arm
INNOMOTION (18) can hold and align an instrument around a
pivot point in 6 degrees of freedom (DOF) over the patient inside
the magnet bore. It found only a limited number of applications
(19, 20) and is no longer commercially available. Another
commercial prototype assistance system is the smaller, second-
generation remote-controlled manipulator using pneumatic air
stepper motors (21) for MR-guided transrectal prostate biopsies
(22). A technically more complex system is the neuroArm (23)
driven by ultrasonic piezoelectric motors, which features re-
motely controlled and exchangeable neurosurgical instruments
and provides the neurosurgeon with both visual control and
RESEARCH ARTICLE
A
B
ST
R
A
C
T
©2019 The Authors. Published byGrapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ISSN 2379-1381 https://doi.org/10.18383/j.tom.2019.00007
266 TOMOGRAPHY.ORG | VOLUME 5 NUMBER 2 | JUNE 2019
haptic feedback. In addition to these commercial systems, sev-
eral other small patient-mounted systems have been recently
presented (13, 24): Monfaredi et al. described a shoulder-
mounted robot using 4 MRI-compatible piezo-motors for needle
placement with 4 DOF (25). Ghelﬁ et al. assessed a patient-
mounted light puncture robot for percutaneous needle interven-
tions that is ﬁxed to the patient’s body to allow for patient
movements (26). The 4 piezoelectric driven motors, which are
placed at the feet to avoid interferences with MR imaging,
enable placement of a needle in 4 DOF through Bowden cables.
Nearly all of these systems depend on sophisticated control
mechanisms that require bulky additional hardware in the MR
room, making it difﬁcult for them to integrate into the clinical
routine (24, 27). Thus, despite the variety and abundance of
system designs, only a few of these design concepts were
converted into commercially available systems for clinical
use (13). Therefore, the exploration and design of novel
assistance systems for MR-guided interventions remain areas
of active research.
Here, we present an alternative patient-mounted assistance
system for image-guided percutaneous needle interventions.
Compared with existing systems, this new GantryMate system
features a ﬂexible, simpler design and is constructed entirely
from plastic material. It can be remotely steered via Bowden
cables to manipulate a needle-guide inside the magnet bore,
i.e., no additional hardware is required for operation. We
tested the assistance system according to American Society
for Testing and Materials (ASTM) standards (28-32), and we
veriﬁed if the MR system’s radiofrequency and magnetic ﬁelds
remain unaffected. To enable automatic scan plane positioning,
we combined GantryMate with a tracking MRI sequence to
automatically detect a passive marker needle-guide and fol-
lowed the device motion during targeting in real time (22,
33-35). In a phantom setting, the lateral puncture accuracy of
needle placements, as well as the procedure time, was assessed.
Furthermore, technical proof of concept in in vivo situations is
shown with the successful alignment of the needle pathway
with basivertebral veins in the vertebrae and a vessel branch in
the liver of a volunteer.
METHODS
Assistance System GantryMate
The assistance system GantryMate (Interventional Systems,
Kitzbühel, Austria) is entirely constructed from electrically non-
conducting, nonmetallic, and nonmagnetic plastic and ﬁber
glass materials (Figure 1). The system is mounted on a base
platform, which is used for gross positioning and can be ﬁxed to
the patient with straps. The system consists of 2 movable plates
(Figure 1, top left) and an instrument holder, which is attached
to the distal end-effector (Figure 1, top right). The plates can
each be moved independently in 2 translational DOF (forward-
backward—FB, left-right—LR) via 4 mechanical adjustment
threads, which are accessible from outside the magnet through
Bowden cables (cf. Figure 1, bottom). Manipulation of the lower
plate moves the entire unit in either FB or LR direction relative
to the base platform (approximate translational range 40 mm
in each direction). Translation (FB and LR direction) of the upper
plate relative to the lower plate causes rotations of the distal
instrument holder (angular range  30° in both directions)
about a pivot point located at the level of the lower plate (cf.
Figure 1, top left).
During targeting, a passive marker is attached to the instru-
ment holder for online device localization and planning of the
needle pathway. Once the marker is correctly aligned with the
target in the patient’s body, a needle is manually inserted
through the marker that now serves as a needle guide, and the
Figure 1. Schematic of the GantryMate assis-
tance system (top, left). The base platform (blue)
allows gross positioning of the device, and the
upper 2 plates (black and red) can be moved
independently in x and y directions. This allows
steering of a distal instrument holder (white ar-
row) through Bowden cable (visible in the bot-
tom image) from outside the magnet bore. The
lower plate (black) translates the instrument
holder in x or y direction, and the upper plate
allows for rotations of the holder (red arrow)
around a pivot point (red dot). The holder can
be equipped with a customized cylindrical
marker (top, right) or a needle sleeve (top, left).
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insertion can be visualized with real-time imaging. Alterna-
tively, a needle sleeve can be attached that allows for the use of
needles with varying diameters.
Device Tracking
For device tracking during the targeting, the GantryMate system
was equipped with a cylindrical passive marker needle-guide
(inner/outer diameter 5/13 mm, length 62.5 mm) ﬁlled with
a contrast agent solution (Magnevist®/H2O: 1/100, Bayer Scher-
ing Pharma AG, Berlin, Germany). To automatically determine
the position and orientation of the passive marker, a previously
developed tracking sequence was used (22, 33-35). The sequence
acquires 2 T1-weighted gradient echo (FLASH) images, which
are oriented perpendicular to the marker’s symmetry axis. In
these images, the marker is seen as a ring-like structure (Figure
2) that can be automatically detected via a phase-only cross-
correlation (POCC) algorithm (33) during online image recon-
struction. Based on the position information, the sequence au-
tomatically aligns the plane of a subsequent imaging acquisition
with the marker direction. For imaging, a different contrast
(balanced steady-state free precession, bSSFP) is used to in-
crease the lesion contrast. The bSSFP image is then displayed
online on a screen in the MR room, and the theoretical needle
trajectory is overlaid to enable targeting maneuvers of the
needle-guide.
MR Safety and Compatibility Measurements
MR experiments were carried out in a 1.5 T whole-body system
(MAGNETOM Symphony, Siemens Healthcare, Erlangen, Ger-
many) with a manufacturer-provided open-loop coil (Flex Loop
Large, Siemens Healthcare) for signal reception. A bottle (diam-
eter 12 cm; Siemens Healthcare) ﬁlled with a solution [(1.25 g
NiSO4  6 g H2O  5 g NaCl)/1000 g H2O] was placed on the
system’s patient table around the magnet’s isocenter. Measure-
ments were conducted without and with the assistance system
placed on top of the phantom bottle to examine image artifacts
and distortions according to the standard ASTM F2119 (30).
Therefore, gradient-echo (GRE) and spin-echo (SE) images were
acquired in sagittal and axial orientations with the following
parameters: GRE: repetition time (TR)/echo time (TE)  500/15
ms, slice thickness  3 mm, slices  20, slice gap  6 mm, ﬂip
angle (FA) 30°, ﬁeld of view (FOV) 350 350 mm, matrix
256 256, bandwidth (BW)  130 Hz/px; SE: TR/TE  500/20
ms, slice thickness  5 mm, slices  20, slice gap  10 mm,
FA  90°, FOV  350  350 mm, matrix  256  256, BW 
130 Hz/px. Afterwards, a dual-echo GRE sequence was used to
assess B0 distortions without and with the device in place:
TR/TE/TE  15/8.76/4.76 ms, slice thickness  5 mm, FA 
15°, FOV  300  300 mm, matrix  256  256, BW  250
Hz/px (Figure 3, left). In addition, 3D GRE images were acquired
(TR/TE 1500/2.6 ms, slice thickness 1.88 mm, FA 30/60°,
FOV  127  240 mm, matrix  128  68, BW  279 Hz/px)
to assess B1 distortions and to calculate a relative FA map
(Figure 3, right) with the double-angle method (36, 37).
Phantom Measurements
The accuracy of the needle positioning was measured in a
phantom experiment with an agar phantom (volume  50 
50  40 mm3) with 13 embedded ﬁducial targets (mean diameter
8.1 mm), which was placed inside a plastic casing that was
shaped like a human torso (Figure 1, bottom). After target
deﬁnition in a 3D GRE localizer data set, the following proce-
dure, including 4 steps, was performed for each target:
1. The passive marker was attached to the instrument holder
at the manipulator’s center position.
2. Instrument positioning and alignment of the needle path-
way with the target were performed under online guidance
with the POCC tracking sequence (Figure 4; FLASH track-
ing images: TR/TE  4.0/2.0 ms, FOV  244  300 mm2,
matrix  156  192, FLASH  15°, slice thickness  10
mm, BW  1180 Hz/px; bSSFP targeting image: TR/TE 
4.0/2.0 ms, FOV  244  300 mm2, matrix  156  192,
bSSFP  70°, slice thickness  5 mm, BW  1180 Hz/px,
TAtot per tracking cycle  1.9 s).
Figure 2. Schematics of the pas-
sive marker tracking sequence.
Two parallel images (blue and
red) are acquired perpendicular
to the symmetry axis of the marker
(left). The position of the ring-
shaped structures can be detected
via a POCC algorithm (middle).
The position information is used to
align a third image along the
marker and to visualize the theo-
retical needle trajectory (right).
The sequence runs continuously
and allows online needle target-
ing procedures.
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3. The passive marker was replaced with a dedicated needle sleeve
for a 16-G needle (Somatex GmbH, Teltow, Germany).
4. The needle was manually advanced into the target under online
monitoringwith a HASTE (Half-FourierAcquisition Single-shot
Turbo spin Echo imaging) sequence (TR/TE  2000/46 ms,
FOV 250 250mm2, matrix 256 256,HASTE 180°,
thickness  5 mm, partial Fourier  4/8, BW  781 Hz/px).
After all targets were successfully punctured, a high-resolu-
tion (0.5  0.5  0.5 mm3) 3D bSSFP data set (TR/TE 
7.52/3.76 ms, FOV  200  150 mm2, matrix  384  288,
bSSFP  70°, thickness  0.5 mm, BW  482 Hz/px) was
acquired to evaluate the needle pathways and assess the
insertion accuracy. Therefore, the distance of each needle
pathway was measured in the gel from the target center using
reformatted multiplanar views (Figure 5).
In Vivo Measurements
To simulate an in vivo application, a volunteer was placed on
the patient table in supine position, and the assistance system
was attached above the abdomen (Figure 6, top left). The assis-
tance system was positioned in its center position, and then a
targeting maneuver was simulated using the circular cross sec-
Figure 3. Frequency difference (left) and rela-
tive ﬂip angle (FA) difference (right) in the phan-
tom between images acquired before and after
the assistance system was placed on the
phantom.
Figure 4. Example of the alignment of the theo-
retical needle trajectory (dashed white) with the
desired target in transversal and sagittal orienta-
tion (top left and right). The location of the track-
ing slices is marked in red. A HASTE sequence
is used for online monitoring of the needle inser-
tion (bottom, left). After the needle is removed,
the needle pathway (yellow arrows) is visible,
which can be used to determine targeting preci-
sion (bottom, right).
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tions of the basivertebral veins in the lumbar vertebra (L2, L3, L4
and L5) as anatomical target structures (Figure 6, top right). The
location and orientation of the GantryMate device were manip-
ulated via the Bowden cables under online tracking guidance
(FLASH tracking images: TR/TE  3.6/1.7 ms, FOV: 380  380
mm2, matrix  154  192, FLASH  15°, slice thickness  10
mm, BW  1042 Hz/px, partial Fourier  6/8; bSSFP targeting
image: TR/TE  3.6/1.7 ms, FOV: 380  380 mm2, matrix 
154  192, bSSFP  70°, slice thickness  5 mm, BW  1042
Hz/px, partial Fourier  6/8, TAtot per tracking cycle  1.3 s)
until the needle pathway was aligned with the target in sagittal
and transversal views.
To test the assistance system in a moving target, a distal
vessel branch of the portal vein was deﬁned as target which is
moving over the breathing cycle (Figure 7). Again, the device
was manipulated under online tracking guidance until the nee-
dle pathway was aligned with the target. Gross alignment was
performed during breathing in a transverse view, and ﬁnal
Figure 5. Reformatted orthogo-
nal multiplanar views of the nee-
dle pathway (red and green
boxes) that deﬁne the bullseye-
view (blue box) for assessment of
the lateral accuracy.
Figure 6. Experimental setup
(top left) for the targeting of sta-
tionary targets (cross sections of
basivertebral veins, top right) in a
volunteer. The targeting procedure
is started in a sagittal view (bot-
tom left), and the projected nee-
dle pathway (dashed white) is
aligned with the predeﬁned target
region in sagittal and transversal
views (yellow circles, bottom mid-
dle and right).
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alignment of the needle pathway was done in a breath-hold
maneuver for a sagittal and transverse view.
RESULTS
No distortion or signal loss artifacts were visible in either the GRE
or SE images (images not shown). B0 ﬁeld and FAmappingwithout
andwith the assistance systems revealed no signiﬁcant inﬂuence of
the device on either the B0 or B1 ﬁeld, respectively (Figure 3). Here,
B0 maps without and with the setup showed a mean frequency
difference of 0.9 Hz, that is, 0.01 ppm (range:6 and 15.5 Hz). The
B1 ﬁeld measurements showed almost no effects because of the
setup with mean relative B1 differences of 0.2%.
The results from the needle experiment in the phantom with
13 ﬁducial targets are summarized in Table 1. Puncturing was
successfully performed in all 13 targets within the mean proce-
dure time (duration for instrument positioning, exchange of
marker and needle sleeve, and needle insertion) of tpuncture 
6.4  1.5 min. The mean lateral distance between the needle
channels and the geometric center points of the targets was
1.7  1.0 mm.
In the in vivo experiment, the passive marker needle guide
could be successfully aligned with cross sections of the basiver-
tebral veins in the lumbar spine. The durations of the individual
targeting procedures are summarized in Table 2 (mean duration
for instrument positioning  2.0  0.5 min). Furthermore, the
passive marker needle guide could be also successfully aligned
with a moving target in the liver. Here, gross alignment was
performed during free breathing (duration  2.7 min) and ﬁnal
ﬁne alignment could be accomplished during short breath holds
for sagittal (duration  15 s) and transverse (duration  5 s)
image orientation, respectively.
DISCUSSION AND CONCLUSION
In this work, a patient-mounted assistance system for MR-
guided needle interventions is presented in combination with an
online POCC device tracking sequence. The assistance system is
designed to move a passive needle-guide inside of a closed-bore
MR system and can be mechanically manipulated from outside
the magnet via Bowden cables.
Table 1. Summary of Measured Diameter, Depth from Phantom Surface, Needle Pathway Angles in FB and LR
Direction, Duration (Procedure Time for Instrument Positioning and Needle Insertion), and Lateral Distance of
Needle Pathway to Target Center for all 13 Targets
Target #
Diameter
(mm)
Depth
(mm)
Angle
FB (°)
Angle
LR (°)
Duration
(min:second)
Lateral
Distance (mm)
1 8.0 53.8 12 16 6:45 1.1
2 8.3 52.9 0 3 4:26 2.0
3 8.1 53.5 16 3 8:46 2.6
4 7.9 53.1 7 3 5:41 3.6
5 7.7 55.9 12 3 7:24 2.6
6 7.5 35.5 17 4 5:59 0.1
7 7.4 33.4 23 1 7:02 1.4
8 8.7 38.4 5 0 6:54 2.3
9 9.0 23.7 28 9 5:27 1.6
10 8.5 23.5 32 19 8:07 0.3
11 8.7 24.2 29 9 8:40 0.7
12 7.8 25.6 16 11 5:01 1.5
13 8.1 20.1 0 0 3:31 2.2
Mean  SDa
(range)
8.1  0.5
(7.4–9.0)a
38  13
(20.1–55.9)
15
(0–32)
6
(0–19)
6:26  1:33
(3:31–8:46)
1.7  1.0
(0.1–3.6)
a Respective mean values and standard deviations (SD) are summarized in the bottom line.
Figure 7. First image of the procedure to align
the projected needle pathway (dashed white)
with the predeﬁned target region (left). Last im-
ages of the procedure in transversal and sagittal
view (middle, right); the needle pathway was
successfully aligned with the target region.
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The assistance system is manufactured from electrically
nonconducting, nonmetallic, and nonmagnetic plastic material.
Measurements revealed no interference with the magnetic or the
radiofrequency ﬁelds of the MR system, as can be seen in the
small B0 frequency differences and small relative B1 distortions
(Figure 3). Thus, according to our measurements, the device can
be classiﬁed as “MR-safe” according to the ASTM F2503 stan-
dard (28). This safety assessment is only valid for the holder
without the instrument (e.g., a needle), which needs to be tested
separately. However, many MR-safe needles are commercially
available, which can be used in combination with the assistance
system.
In combination with a passive POCC tracking sequence, the
assistance system provided an accurate and versatile tool for
MR-guided needle interventions. In the phantom measurement,
all 13 targets were successfully punctured. The system was
intuitive to use, no special training was required, and the sur-
rounding adjacent targets were not unintentionally perforated.
The mean procedure duration (6.5 min) and the lateral accuracy
(1.7 mm) in this evaluation are comparable to values found in
previous studies (22, 33-35).
In the in vivo experiment, the device could target stationary
targets such as deep-lying cross sections of the basivertebral
veins in the lumbar vertebrae. Here, the needle trajectory could
be successfully aligned with the targets in 2.0  0.5 min, which
would allow one to perform multiple procedures in a single
setting. Furthermore, the device was tested in a moving target—
here, a hepatic vessel branch was chosen as a ﬁducial target
because the anatomical structure can be unambiguously identi-
ﬁed on MR images—and also follows the movement of the liver
during respiratory motion. Again, the targeting procedure could
be performed without any special training. Gross targeting could
be achieved during breathing motion and ﬁne adjustment with
only 2 breath holds in 20 seconds, which is in line with require-
ments for abdominal procedures.
The current realization of the system allows planning of the
lateral needle pathway, whereas the depth of the needle inser-
tion has to be manually deﬁned. For this, the target depth is
either predeﬁned in the targeting images before needle insertion.
Alternatively, the needle insertion can be monitored continu-
ously using image sequences which are less prone to needle-
induced artifacts. Here, real-time monitoring of the insertion has
been realized with the spin-echo single-shot technique HASTE,
which is insensitive to ﬁeld inhomogeneities and provides an
excellent T2 contrast but is leading to signal saturation and
increased speciﬁc absorption rate (SAR) values. In this context,
accelerated SE-based sequences such as targeted-HASTE (38)
were presented for an optimized visualization of the needle
insertion. However, in some needle placement scenarios, depth
control is not needed. For example, in arthrography contrast
agent insertions, the needle is inserted until the tip touches the
bone (25).
Currently, targeting the passive marker is not possible as
soon as the needle is introduced in the marker because the
needle artifacts distort the ring-shaped cross section required for
POCC tracking. However, it would be beneﬁcial to place the
needle inside of the marker from the very beginning of the
procedure because the total procedure time could be reduced as
the needle would only have to be mounted once and no ex-
change of passive marker and needle guide would be required.
To enable targeting with the needle inside the marker, again fast
spin echo sequences could be used which reduce the needle
artifact. Accurate tracking of the marker with the needle in place
could be highly advantageous to detect needle deﬂections from
the planned needle trajectory during insertion. Here, the inter-
ventionalist could use the direct visual feedback to stabilize the
needle trajectory by manual needle rotation (39).
In its current implementation, the device setup with Bowden
cables is simpler than that of other assistance systems. Never-
theless, it could be expanded in future for example, with more
advanced robotic technologies for fully remote control. With
its ﬂexible design, it is not restricted to single interventional
scenarios and could be used in many abdominal applications,
for example, transgluteal prostate or kidney biopsies. The
main components of the device are reusable and only small
parts (distal instrument holder, marker, instruments) are
made as sterile disposables, which might be important for
clinical applicability.
The presented combination of the MR-safe assistance sys-
tem and online POCC tracking sequence could also be used for
other MR-guided interventions. For example, RF ablation elec-
trodes could be placed in the target regions, and the thermal
destruction would be subsequently monitored with MR temper-
ature imaging. All these procedures would beneﬁt from accel-
eration of the POCC tracking sequence. This can be achieved, for
example, with simultaneous acquisition of the tracking images
(35) or with radially undersampled projection imaging of the
passive marker (40). A higher temporal resolution would allow
better tracing of anatomical targets during breathing motion.
In conclusion, we presented a simple, accurate, and versatile
assistance system in combination with a passive marker track-
ing sequence, which might be a valuable tool to facilitate MR-
guided interventions.
Table 2. Summary of Measured Times of
Needle Pathway Alignment with the Vertebral
Veins
Lumbar
Vertebra
Diameter
(mm)
Duration
(min:second)
L2 7.7 02:18
L3 9.4 03:03
L4 8.7 01:34
L5 8.2 02:04
L2 7.7 01:55
L3 9.4 01:56
L4 8.7 01:50
L5 8.2 01:36
Mean  SDa (range) 8.6  0.6 (7.7–9.4) 2:00  0:30 (1:34–3:03)
a Respective mean values and standard deviations (SD) are summarized
in the bottom line.
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A magnetic resonance (MR)-, computed tomography (CT)-, single-photon emission computed tomography
(SPECT)-, and positron emission tomography(PET)-compatible carbon-ﬁber sheet resistor for temperature main-
tenance in small animals where space limitations prevent the use of circulating ﬂuids was developed. A 250
 carbon-ﬁber sheet resistor was mounted to the underside of an imaging cradle. Alternating current, operat-
ing at 99 kHz, and with a power of 1-2 W, was applied to the resistor providing a cradle base temperature of
	37°C. Temperature control was implemented with a proportional–integral–derivative controller, and tempera-
ture maintenance was demonstrated in 4 mice positioned in both MR and PET/SPECT/CT scanners. MR and CT
compatibility were also shown, and multimodal MR-CT-PET-SPECT imaging of the mouse abdomen was per-
formed in vivo. Core temperature was maintained at 35.5°C  0.2°C. No line-shape, frequency, or image
distortions attributable to the current ﬂow through the heater were observed on MR. Upon CT imaging, no
heater-related artifacts were observed when carbon-ﬁber was used. Multimodal imaging was performed and
images could be easily coregistered, displayed, analyzed, and presented. Carbon ﬁber sheet resistors pow-
ered with high-frequency alternating current allow homeothermic maintenance that is compatible with multi-
modal imaging. The heater is small, and it is easy to produce and integrate into multimodal imaging cradles.
INTRODUCTION
In vivo imaging using positron emission tomography (PET),
single-photon emission computed tomography (SPECT), and
x-ray computed tomography (CT) is increasingly applied in
conjunction with magnetic resonance imaging (MRI). In some
cases, these systems are colocated within a common gantry
system such that the animal is moved between modalities under
scanner control. In contrast, where this is not possible, it is
advantageous to hold the animal in a cradle that can be moved
with the animal in situ such that the animal position within the
cradle is constant and image registration is straightforward
(1-3). Regardless of the scanner-speciﬁc cradle arrangements, it
is essential that animals are actively provided with heat to avoid
hypothermia that is a consequence of anesthesia (4, 5). It is also
essential that the method used for providing thermoregulation is
compatible with all of the imaging systems being used, and that
it can operate within the physical and technical constraints of
each system. MRI scanners, in particular, frequently operate
with limited space owing to the loading requirements of radio-
frequency (RF) coils (6) and this hinders the use of the most
widely used heating systems that include heat lamps, circulating
warmed ﬂuids and air, prewarmed heat reservoirs, and exother-
mic chemical reaction pads (4, 5, 7-10). MRI scanners must
avoid the use of large volumes of metal and even small amounts
of ferromagnetic materials, while CT scanners, and by inference
PET and SPECT scanners where CT-derived intensity corrections
are made, must avoid materials of high atomic number in order
to avoid image corruptions derived from severe x-ray attenua-
tion (11). MRI must also avoid the formation of magnetic ﬁeld
inhomogeneities consequent to the delivery of electric current.
Compact magnetic resonance (MR)-compatible heaters for
homeothermic maintenance in small animals have recently been
described (7, 12). In one design, a resistive electrical heater was
formed from a tightly-wound twisted pair wire, interfaced to a
homeothermic maintenance controller. This heater can be im-
plemented very easily on existing electrical heater systems, and
it provided adequate heating performance without causing any
signiﬁcant distortion of the magnetic ﬁeld or the images. Un-
fortunately, it is not robustly deformable, and any usage-related
change in shape, resulting from normal wear and tear, can lead
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to imperfect spatial cancellation of stray magnetic ﬁeld. An
alternative heater element was formed from a narrow-gauge
wire connected to a high-frequency (99 kHz) alternating current
(AC) power source. This frequency was chosen because its cycle
time, 10.1 s, was short enough that long-term ﬁeld inhomo-
geneities, and consequent MR image distortions, were absent,
while any sound resulting from the heater’s use in a magnetic
ﬁeld was inaudible, even for small rodents (12). In contrast to
the twisted pair wire, the use of temporal, rather than spatial,
averaging of stray magnetic ﬁelds toward zero allowed the use
of arbitrarily shaped resistors that could be deformable.
While both of these heater elements are compatible with
MR, the presence of copper (atomic number, z  29) leads to
excessive x-ray attenuation and streak artifacts in CT images.
This obscures anatomy and pathology, and it corrupts the CT-
based attenuation maps used for quantiﬁcation of PET and
SPECT images. As such, these types of electrical heaters cannot
be used with CT unless they can be formed from an electrically
conductive, low-atomic-number element, such as lithium, be-
ryllium, or carbon, as these do not cause attenuation-related
image corruptions. Lithium is highly reactive in air; beryllium is
very expensive and toxic; while carbon, in the form of resin-
embedded carbon-ﬁber is chemically inert to air, cheap, non-
toxic, and easy to work, and is widely used as a heating element
in a range of applications. Here, we present a high-frequency
AC-based heating resistor in which the metal wire has been
replaced by a custom-shaped carbon-ﬁber sheet to effect a
planar heater element that is both MR- and CT-compatible and
which can, as a result, be used with CT-corrected PET and
SPECT imaging. Improved stability of temperature control was
achieved using a proportional–integral–derivative (PID) device
that reduced the output power as the temperature approached its
target. This is crucial to minimize temperature ﬂuctuations,
especially as the MRI system itself delivers an unspeciﬁed and
variable amount of heat to the animal during operation.
In this report, we describe the use of a carbon-ﬁber heater,
show its multimodal imaging compatibility, and show the gen-
eration of a multimodal image of the mouse abdomen formed
using dynamic contrast-enhanced MRI (DCE-MRI), CT, 99mTc
SPECT, and 18F (PET)SPECT; (PET)SPECT describes the SPECT
detection of 511-keV photons as used in conventional PET
imaging and allows true simultaneous imaging of PET and
SPECT isotopes.
MATERIALS AND METHODS
Ethics Statement
All animal studies were performed in full compliance with na-
tional legislation and with the approval of the Oxford University
Animal Welfare and Ethical Review Body.
Imaging Cradle and Carbon Fiber Sheet-Resistive
Heater Assembly
A ﬂat-based MR- and CT-compatible animal support cradle was
designed using computer-aided design (CAD) software (Solid-
Works, Dassault Systèmes, Hammersmith, UK) and printed using
acrylonitrile butadiene styrene (ABS) plastic, on a 3D printer (HP
Designjet 3D, Bracknell, UK). A 250- resistive heater element
formed from a 0.75-mm-thick carbon-ﬁber sheet (764-8700, RS
Components, Corby, UK) which was cut into 4-  3-mm-wide
legs, each 120-mm in length and 1 mm apart, and glued to the
underside of the cradles as shown in Figure 1B. As such, the
heater element was positioned 1.68 mm below the lowest part of
the object to be imaged.
The heater volume was 	1.5 mL, occupying 3.05% of the
volume of the small-diameter RF coil used for the validation
studies reported in this work. The cradle was assembled with an
anesthetic gas supply tube, a heater power cable, a ﬁber optic
rectal temperature probe, and a pneumatic respiration monitor
(Figure 1C). All services were supplied using “quick-ﬁt” connec-
tors so that the cradle could be disconnected from one imaging
system and reconnected on the other quickly and without any
risk of the animals recovering from the anesthetic depth used
before disconnection.
AC Heating Control Units
Core body temperature was measured using an optical rectal
temperature probe (OTP-M-X-62F2.5-1.5(PTFE/PVC)-XN-7GT-
M1-PV0014a, Opsens Solutions, Québec, Canada) connected via
Figure 1. Carbon ﬁber sheet–resistive heater em-
bedded in a 3D-printed, ﬂat-base multimodal im-
aging cradle. Proportional–integral–derivative
(PID) controller (A); bottom view of the cradle (B);
top view of the cradle (C); and thermal image of
the cradle surface (D). The cradle contains a
heater and (*) a mouthpiece assembly consisting
of a base block, a vertical and horizontal adjust-
able mouth bar, and an anesthetic gas delivery
tube, (¦) is a pressure balloon for respiration mon-
itoring, (#) is an optical ﬁber for temperature mon-
itoring, and (†) is a cover sheet to contain anes-
thetic gas. The current wires and metal couplings
to the carbon-ﬁber are located beyond the imag-
ing ﬁeld of view (FOV) so do not present image
distortions.
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a 10-m ﬁber-optic extension to an AccuSens 4-channel Signal
Conditioner (ACS-P4-N-62SC Opsens Solutions, Québec, Can-
ada).
Temperature control was driven using a PID controller
(CN16PT-305-DC, OMEGA Engineering Ltd., Manchester, UK;
Figure 1A). This controller takes the analog output of the Ac-
cuSens unit as the temperature input signal, providing gain
control signal to an AC power circuit, which comprises a Pierce
oscillator operating at 99-kHz output and a power ampliﬁer
(LM1875, Texas Instruments, Dallas, Texas). The maximum out-
put power was limited to 	2 W for the heating elements de-
scribed, although this could be increased or decreased for other
heating elements. The maximum temperature of the cradle sur-
face was 37.0°C, when a maximum output gain was used indef-
initely, and this was demonstrated using a thermal imaging
camera (Testo 875-1i, RS Components, Corby, UK). This temper-
ature was selected to ensure thermal burns could not result from
the use of this heating apparatus. All animal service signal and
power leads entering and leaving the magnet room were passed
through RF ﬁlters (series 700 high-performance ﬁltered connec-
tor, 4000 pF capacitance Pi ﬁlter type, part number SCI 56-715-
005, API Technology Corp., Milton Keynes, UK). These animal
services all operate at low frequencies (101 kHz) and can pass
through the ﬁlters, while higher frequencies, some of which
could affect MR image quality, cannot.
Animal Preparation
Female 6- to 8-wk-old CBA/Crl mice (Charles-River, Harlow,
UK) were housed in individual ventilated cages at constant
temperature and humidity, and water and food were freely
available. Anesthesia was induced and maintained using isoﬂu-
rane (1%–4%) in air/oxygen (v/v 80/20); the animals recovered
afterwards with no ill effect. Induction and recovery were per-
formed in a heated unit with a base temperature of 	37°C.
Rectal temperature was set at 36.0°C using the aforementioned
heater driver. The depth of anesthesia was monitored using a
pressure balloon system measuring the animal’s respiration rate,
which was maintained at 60–90 breaths/minute. Respiratory
signals were processed for use in a gating control of the scanner
to allow for respiratory synchronized MRI.
Assessment of Homeothermic Maintenance in Mice
For validation of thermal stability, mice (n  4 for MRI; n  4
for SPECT/(PET)SPECT/CT) were anaesthetized and placed on
the imaging cradle in the MRI or SPECT/(PET)SPECT/CT scanner.
Rectal temperature was monitored for 50 minutes in total after
which the animals recovered.
For MRI, the additional heat load of high-duty cycle MRI
scanning was included after the animals had reached their
equilibrium temperature.
Assessment of MRI Compatibility
MR compatibility of the heater element was tested in a water gel
phantom (Hydrogel, 70-01-5022, ClearH2O) by using single-
shot Point-RESolved Spectroscopy (PRESS) spectroscopy and
2D fast low angle shot (FLASH) imaging, and in vivo in the
mouse using respiratory-gated 2D FLASH and cardiorespirato-
ry-gated 3D FLASH imaging. In all cases, the same acquisition
was repeated for the heater turned on and off.
MRI was performed on a 7 T, 210-mm VNMRS horizontal
bore preclinical imaging system equipped with a 120-mm bore
gradient insert (Varian Inc., Palo Alto, California). RF transmis-
sion and reception were performed using a 26-mm-diameter,
100-mm-long RF coil for system validation purposes, and a
32-mm-diameter, 45-mm-long RF coil for multimodal imaging
(Rapid Biomedical GmbH, Rimpar, Germany).
Single-shot PRESS spectra from a 2  2  2 mm3 voxel
positioned at the bottom edge of the water gel phantom, closest
to the heater (
1.68 mm from the heater), were acquired with
echo time (TE)  15 milliseconds, bandwidth  4 kHz, and
complex points 2048. Raw data were zero-ﬁlled to give a real
spectrum of 8192 points with 2-Hz exponential line broadening.
The full width at half maximum (FWHM) linewidth of this voxel
was 	20 Hz. Spectra were acquired with the heater turned off
and on. In addition, a difference spectrum for the heater turned
on and off was compared with a spectrum acquired with the
heater off. Ten repetitions of a multi-slice spoiled gradient echo
scan were acquired on this gel phantom: repetition time (TR) 
100 milliseconds, TE  10 milliseconds, thickness (THK)  1
mm, ﬁeld of view (FOV)  100  25 mm2, matrix  384  96,
ﬂip angle (FA)  30°. Dummy scanning was performed for 50
seconds before data acquisition to stabilize a steady state. The
total scan time was 146 seconds for 10 repetitions, with each
repetition alternating between the heater turned off and on.
In vivo, a multi-slice, constant TR, spoiled gradient echo
with respiration-gating and reacquisition (13) was performed:
TR  1000 milliseconds, TE  6 milliseconds, THK  1 mm,
FOV 100 25 mm2, matrix 512 128, FA 30°. The total
scan time was 195 seconds. ImageJ was used to calculate the
difference image between the heater turned off and on (14). Ten
repetitions of a cardiorespiratory-gated 3D FLASH scan with
reacquisition (15) were acquired, with each repetition alternat-
ing between the heater turned off and on, and 10 further repeats
were acquired with the heater just turned on: TR  3 millisec-
onds, TE  1.28 milliseconds, FOV  108  27  27 mm3,
matrix  512  128  128, gradient spoiling with 167 mT/m
for 0.85 milliseconds in all three axes, RF hard pulse duration
16 s, FA  5°, and RF spoiling. The total scan time was 5
minutes for the 20 repetitions. Dummy scanning was performed
for at least 20 seconds before data acquisition to stabilize a
steady state. Image intensity as a function of the repetition
number was determined in ImageJ, using a square ROI posi-
tioned proximal to the heater.
For multimodal imaging, respiratory-gated 3D FLASH im-
aging was performed repeatedly to effect DCE-MRI.
Signal-to-noise ratio (SNR) was tested using measurements
of the pulse power required to generate a FA excitation pulse of
90°, and by acquisition of a nongated 3D FLASH scan (as per the
DCE scan described above), using a postmortem animal (so as
not to be affected by the cardiorespiratory motion) and in the
presence and absence of the carbon-ﬁber heating element.
Assessment of CT Compatibility
CT compatibility was tested in vivo in the absence of any heater
and in the presence of either a copper wire or a carbon-ﬁber
sheet heater element. Whole-body CT was performed using the
VECTor4CT system (MILabs, Utrecht, The Netherlands). Images
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were acquired at 50 kV and 0.24 mA using continuous rotation
(40°/s) and were reconstructed using a cone-beam ﬁltered back-
projection (Feldkamp algorithm) on a 0.2-mm voxel grid. Beam
hardening and ring artifacts were corrected, and the voxel num-
bers were converted into Hounsﬁeld units by using a premea-
sured calibration factor.
Demonstration of Multimodal (PET)SPECT/SPECT/CT/MR
Imaging
Multimodal MR-CT-(PET)SPECT-SPECT imaging of the abdo-
men, including the kidneys, was performed on animals that were
held in the same cradle as for MRI and using anesthesia and
physiological maintenance as described above.
(PET)SPECT and SPECT imaging was performed using the
single-gantry VECTor4CT system ﬁtted with the HE-UHR-RM
PET/SPECT collimator (1.8-mm pinholes); (PET)SPECT describes
the SPECT detection of 511-keV photons as used in conven-
tional PET imaging. CT, SPECT, and (PET)SPECT imaging were
performed immediately before MRI; 111In-citrate and 18F-ﬂuo-
rodeoxyglucose (FDG) were used for SPECT and (PET)SPECT
imaging, respectively. DCE was performed (scan details in As-
sessment of MRI Compatibility) with a scan time of 	10–15
s/frame. Contrast agent (100 L, Gadospin, Viscover, Germany)
was infused in the lateral tail vein over 17 seconds at the start of
frame 11/50.
Data were acquired in list mode (0–1200 keV) using MILabs
acquisition software v7.39. Triple energy window–based scatter
correction was applied for each photon peak window (18F: 460-
562 keV with background windows set to 439.6–460 keV and
562–582.4 keV; 111In: 155.7–190.3 keV and 222.3–271.7 keV
with background windows set to 148.8-155.7 keV, 190.3–197.2
keV, 212.4–222.3 keV, and 271.7–281.6 keV). All images were
reconstructed with MILabs reconstruction software v3.24 on
0.8-mm isotropic 3D voxel grids using dual matrix similarity
regulated ordered-subset expectation maximization (dual ma-
trix SROSEM) (8). After reconstruction, the (PET)SPECT, SPECT,
and their corresponding CT data were coregistered and resa-
mpled to equivalent 200-m voxel sizes. CT-based attenuation
correction was applied. Reconstructed images were viewed and
analyzed using PMOD v.3.37 (PMOD Technologies, Zurich,
Switzerland). 111In-citrate was produced as follows: 50 MBq of
111InCl3 (Curium, UK) was incubated with 0.05M sodium citrate
(Sigma-Aldrich, UK) in a total volume of 0.17 mL at 37°C for
1 h; pH was adjusted with 1M NaOH. 111In-citrate (SPECT; 10.95
MBq) and 18F-ﬂuorodeoxyglucose (FDG, (PET)SPECT; 10.55
MBq) were coinjected through a cannula into the lateral tail vein,
and data were acquired for 12 minutes (2 bed positions containing
both kidneys; 21 frames of 35 seconds; injection during frame,
2/20, lasting for 2 frames; 0–1200 keV). Frames 16–21 were
summed and reconstructed into 1 imaged (4 iterations). A CT image
(scan details in Assessment of CT Compatibility) was acquired for
anatomical referencing and to aid coregistration between CT,
SPECT, (PET)SPECT, and DCE-MRI. Following CT, SPECT, and
(PET)SPECT imaging, the cradle containing the mouse in situ was
transferred to MRI for DCE-MRI (scan details in Assessment of MRI
Compatibility). MR and CT images were aligned and overlaid using
rigid-body registration. The resulting transformation matrix was
used to overlay the SPECT and (PET)SPECT images onto the MR
and CT images.
Further MR-CT-(PET)SPECT imaging has been performed
using this heating system in several hundred mice undergoing
study for other purposes.
RESULTS
Homeothermic Maintenance
Ambient room and magnet bore temperature was 19.3°C and
20.4°C, respectively, as measured with the ﬁber optic tempera-
ture probe.
For a set target temperature of 36.0°C, the core temperature
equilibrated within 20 minutes and was maintained at 35.5°C
0.2°C in 8 CBA mice (Figure 2); the animals recovered quickly
and without incident. The animal’s initial heat loss upon induc-
tion of anesthesia recovered within 10 and 15 minutes for
SPECT/(PET)SPECT/CT (Figure 2A) and MRI (Figure 2B), respec-
tively. A stable core temperature of 35.6°C  0.1°C was reached
for MRI when an additional heat load of high-duty-cycle scan-
ning was applied (Figure 2B).
As the animals approached the target temperature of 36.0°C,
the current delivered through the resistor was reduced by the
PID to avoid any overheating. The PID also limited the maxi-
mum temperature of the upper surface of the cradle to 	37°C,
even when the temperature controller is functioning continually
at its maximum output. In addition, the thermal imaging camera
showed a homogenous heat distribution along the cradle surface
(Figure 1D).
MRI Compatibility
Spectral and imaging distortions resulting from the use of a
current ﬂow through the heater elements were not seen (Figures
3 and 4). The MR spectrum acquired from a PRESS voxel in a
water gel phantom showed no line–shape distortions or fre-
quency shifts attributable to the current ﬂow through the heater
(Figure 3A). A difference spectrum acquired with the heater
turned on and off was compared with the spectrum acquired
with the heater turned off; both are shown in Figure 3B. The
latter spectrum is displayed in the absolute value mode, and the
difference spectrum was magniﬁed 10 to render the difference
spectrum clearly. The spectra show that the current ﬂowing
through the heater has a negligible effect on the proton reso-
nance frequency at distances exceeding 1.68 mm, the thickness
of the cradle. We have not further tested the minimum operating
distance at which distortions could occur. Similarly, no distor-
tions attributable to the current were observed in the same water
gel phantom in 2D FLASH imaging (Figure 3B), with the differ-
ence image showing negligible residual image intensity. In vivo
imaging using respiratory-gated 2D FLASH (Figure 4A) and
cardiorespiratory-gated 3D FLASH (Figure 4B) conﬁrmed the gel
phantom data as again no distortions attributable to the current
ﬂow were observed. In all cases, no differences were observed
when the heater was turned off and turned on, which was further
emphasized when the signal intensity was plotted against scan
repetition (Figure 4C).
For a postmortem mouse with the heater pad in position, a
1.5-dB increase in reference pulse power was required. SNR for
5  5 voxel regions of interest positioned in the liver (centrally
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in the coil) and at the extreme edge of the z-FOV was reduced by
	20%, approximately in line with the increase in reference
pulse power, as described elsewhere (6) (SNR 12.52 and 10.25
for the absence and presence of the heater, respectively). The
loss in SNR was a direct consequence of loading interactions
with the tune/match circuits as the variable ranges of some of
the tuning and matching capacitors were operated at their ex-
tremes. The size of the effect is dependent upon the exact
position of the heater within the coil and its tune/match circuits
and upon the size of both heater and coil.
CT Compatibility
Imaging distortions resulting from the presence of the carbon-
ﬁber heater element were not seen (Figure 5B). The presence of
the copper wire heater element produced severe image streaking
(Figure 5A), organs were poorly deﬁned, and CT intensities were
poorly estimated.
Multimodal PET/SPECT/CT Imaging and MRI Imaging
A composite image formed from DCE-MRI, CT, 111In SPECT, and
18F (PET)SPECT is shown in Figure 6. The CT and MR images
were used to drive the rigid-body registration.
Multimodal (PET)SPECT/SPECT/CT/DCE-MRI imaging was
performed, and images could be easily coregistered, displayed,
analyzed, and presented (Figure 6). The kidneys as rendered
from the MRI image overlaid well with those rendered from the
CT, (PET)SPECT, and SPECT images.
Figure 2. Homeothermic mainte-
nance of core temperature in
CBA mice using a carbon-ﬁber
sheet resistor powered with high-
frequency AC under PID control.
The target rectal temperature was
set to 36.0°C. Core temperature
of 4 mice placed into the SPECT/
(PET)SPECT/CT scanner (A). Core
temperature of 4 mice placed
into the MRI scanner (B). The ar-
row indicates when respiratory-
gated balanced steady-state free-
precession (bssfp) imaging was
initiated to replicate the addi-
tional heat load of high-duty-cycle
magnetic resonance imaging
(MRI) scanning.
Figure 3. Impact of current ﬂow through the carbon-ﬁber sheet heater element on MRI of a water gel phantom. PRESS
pulse-acquire spectroscopy with the heater turned off and on (A). The image shows the placement of the 2-mm-cubic
PRESS voxel that was located 3, 7, and 5 mm off-isocentre in the z, y, and x axes, respectively, such that it was posi-
tioned as close to one of the heater legs as possible; absolute value display of the spectrum showing the water reso-
nance with the heater turned off (top trace) and the difference spectrum from acquisitions made with and without current
ﬂow through the heater (bottom trace) (B). The intensity of the difference spectrum is scaled 10 higher than the top
trace and the absolute value display was used for clarity of display of the residual subtraction error. T1-weighted 2D
FLASH MRI on a water gel phantom with the heater turned off (left column) and on (right column) (C).
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DISCUSSION
The power dissipation of the carbon-ﬁber sheet heater allowed
homeothermic maintenance of the animals. The maximum
power delivery of 	2 W provided a maximum cradle tempera-
ture of 	37°C, thus avoiding any possibility of burns, and all
animals recovered without incident. Animals entered the study
with temperatures in the range of 36.3°–37.3°, presumably as a
result of a different activity level ranges of the mice, local
environment stability, and exact positioning of the rectal ther-
mometer tip within the body. The homeothermic maintenance
was performed using a custom-made PID-based temperature
controller in conjunction with a standard commercial thermom-
eter. This resulted in automated temperature maintenance for
MR, (PET)SPECT/SPECT, and CT applications with a ﬂuctuation
of 0.1°C at	0.5°C below the target temperature. Given that this
heating system is used in imaging scanners that are both ac-
tively cooled and heated simultaneously, we accepted that this
0.5°C PID undershoot error was tolerable, especially as the tem-
peratures were stable. The heat delivery, assessed with a thermal
imaging camera (Figure 1D), was homogeneous when compared
with that achieved with our previous versions of wire heater
elements for which the wires ran markedly hotter than the
average temperature of the heater pads (thermal images of the
wire resistors not shown). Homeothermic control of the core
temperature was shown, even in the presence of additional heat
input from the scanner. The latter scan-induced heating can also
be used to reduce the time necessary for the animal to recover
from its initial heat loss following anesthetic induction.
MR compatibility of the AC-driven carbon-ﬁber heater was
shown in localized spectroscopy and FLASH imaging (Figures 3
and 4). The equivalence of spectra and images acquired in the
presence and absence of AC heating shows that the heater
element delivers heat in a manner that does not corrupt the
imaging process, and the carbon-ﬁber material does not lead to
any marked image distortions.
CT-compatibility was shown in Figure 5. The absence of
attenuation-derived streak artifacts provides good image quality
that enables quantitative analysis of image intensities. This was
not the case where the copper wire heater was used for which
signiﬁcantly streak artefacts were observed. As such, the car-
bon-ﬁber sheet heater performed favorably when compared
with the copper wire heater.
Integration of the carbon-ﬁber heater into the imaging
cradle was straightforward, and the low space requirement of
Figure 4. Impact of current ﬂow through the carbon-ﬁber sheet heater element on in vivo MRI of the mouse. T1-
weighted in vivo whole-body respiration-gated 2D FLASH MRI with the heater turned off (top) and on (middle) (A). The
bottom image displays the difference image between both images. Cardiorespiratory-gated whole-body 3D FLASH MRI
with the heater turned off (left column) and on (right column) (B). The average intensity over a square, placed close to
the heater surface, was plotted for 20 repetitions with the heater turned on (black dots) or off (orange dots) (C).
Figure 5. Impact of the heater material on com-
puted tomography (CT) image quality. CT imag-
ing using the 150-&micro;m-diameter copper wire
heater (A) or the carbon-ﬁber sheet heater (B).
Streak artifacts owing to the presence of the
heater are absent when using the carbon-ﬁber
heater, and the image intensities remain intact.
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the heater allowed the imaging to be performed in the small-
est RF coil appropriate for whole-body imaging. The carbon-
ﬁber heating element reduced SNR by 	15%–20%, equating
to the use of an 	30-mm, rather than the 26-mm, diameter
coil assuming that SNR is proportional to 1/coil volume (6).
While the use of larger RF coils may allow temperature
maintenance using circulating ﬂuids in MRI, they are not
necessarily an option in space-limited, small-bore collima-
tors for PET and SPECT imaging, or when direct access to the
animal is required. In such cases, the heating system de-
scribed provides an elegant solution.
Moreover, by using CAD software in conjunction with a 3D
plastic printer, it is very simple to design and deploy imaging
cradles that feature integrated carbon-ﬁber heater elements. In
our facility, we have produced many replicates of the heater
element, which are then integrated into several different shapes
and sizes of cradles, each of which has identical spaces and
mounting points for the heater elements. The cradles also have
integrated locating adaptors so that they can be easily posi-
tioned on scanners supplied by different manufacturers, each
with their own bespoke mounting systems. Having performed
the scans, the undistorted MR and CT images could be registered
using a simple rigid-body registration. As the CT, SPECT, and
(PET)SPECT images were generated within the same system, it
was straightforward to overlay the SPECT and (PET)SPECT im-
ages onto the MR images and produce the composite image
shown in Figure 6. This image shows, to a ﬁrst approximation,
blood volume from DCE-MRI, glucose distribution, and renal
excretion to the bladder from FDG (PET)SPECT, renal excretion
to the bladder of 111In-citrate from SPECT, and anatomical
deﬁnition of the skeleton from CT.
In conclusion, carbon-ﬁber sheet resistors powered with
high-frequency AC allow homeothermic maintenance that is
compatible with multimodality imaging using MR, CT, PET, and
SPECT. The heater is small, and easy to produce, and integrate
into cradles for multimodal imaging.
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Figure 6. Multimodal imaging of
a mouse using the carbon-ﬁber
sheet–resistive heater embedded in
a 3D-printed, ﬂat-base, multimodal
imaging cradle. The skeleton, kid-
neys, and major vessels to the kid-
neys (*) are marked up. The skele-
ton (white) was imaged by CT,
while 111In-citrate (red), 18F-ﬂuoro-
deoxyglucose (purple), and gadodi-
amide (green) were used for
SPECT, (PET)SPECT, and DCE-MRI
of the kidneys, respectively. Each
panel shows an additional layer of
the coregistered, segmented image:
CT  MRI (A), CT  MRI  SPECT
(B), CT  MRI  (PET)SPECT (C),
CT  MRI  (PET)SPECT  SPECT
(D).
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